Jacqueline Crawley - Publications

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 

122/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Jones KL, Pride MC, Edmiston E, Yang M, Silverman JL, Crawley JN, Van de Water J. Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism. Molecular Psychiatry. PMID 29955164 DOI: 10.1038/s41380-018-0126-1  0.329
2017 Yan L, Shamir A, Skirzewski M, Leiva-Salcedo E, Kwon OB, Karavanova I, Paredes D, Malkesman O, Bailey KR, Vullhorst D, Crawley JN, Buonanno A. Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. Molecular Psychiatry. PMID 28322273 DOI: 10.1038/mp.2017.22  0.434
2015 Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben HM, Baker S, Crawley JN. GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2228-39. PMID 25754761 DOI: 10.1038/npp.2015.66  0.359
2014 Bales KL, Solomon M, Jacob S, Crawley JN, Silverman JL, Larke RH, Sahagun E, Puhger KR, Pride MC, Mendoza SP. Long-term exposure to intranasal oxytocin in a mouse autism model. Translational Psychiatry. 4: e480. PMID 25386957 DOI: 10.1038/Tp.2014.117  0.308
2013 Jones-Davis DM, Yang M, Rider E, Osbun NC, da Gente GJ, Li J, Katz AM, Weber MD, Sen S, Crawley J, Sherr EH. Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T⁺ tf/J mouse model of autism. Plos One. 8: e61829. PMID 23613947 DOI: 10.1371/Journal.Pone.0061829  0.617
2013 Wöhr M, Silverman JL, Scattoni ML, Turner SM, Harris MJ, Saxena R, Crawley JN. Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behavioural Brain Research. 251: 50-64. PMID 22820233 DOI: 10.1016/J.Bbr.2012.07.024  0.553
2013 Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 64: 268-82. PMID 22801296 DOI: 10.1016/j.neuropharm.2012.07.013  0.379
2012 Ey E, Yang M, Katz AM, Woldeyohannes L, Silverman JL, Leblond CS, Faure P, Torquet N, Le Sourd AM, Bourgeron T, Crawley JN. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes, Brain, and Behavior. 11: 928-41. PMID 22989184 DOI: 10.1111/J.1601-183X.2012.00849.X  0.582
2012 Brielmaier J, Matteson PG, Silverman JL, Senerth JM, Kelly S, Genestine M, Millonig JH, DiCicco-Bloom E, Crawley JN. Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. Plos One. 7: e40914. PMID 22829897 DOI: 10.1371/Journal.Pone.0040914  0.309
2012 Yang M, Bozdagi O, Scattoni ML, Wöhr M, Roullet FI, Katz AM, Abrams DN, Kalikhman D, Simon H, Woldeyohannes L, Zhang JY, Harris MJ, Saxena R, Silverman JL, Buxbaum JD, ... Crawley JN, et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6525-41. PMID 22573675 DOI: 10.1523/Jneurosci.6107-11.2012  0.523
2012 Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Science Translational Medicine. 4: 131ra51. PMID 22539775 DOI: 10.1126/Scitranslmed.3003501  0.537
2012 Yang M, Abrams DN, Zhang JY, Weber MD, Katz AM, Clarke AM, Silverman JL, Crawley JN. Low sociability in BTBR T+tf/J mice is independent of partner strain. Physiology & Behavior. 107: 649-62. PMID 22245067 DOI: 10.1016/J.Physbeh.2011.12.025  0.591
2012 Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, Weinberger DR. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Molecular Psychiatry. 17: 85-98. PMID 20956979 DOI: 10.1038/Mp.2010.106  0.65
2012 Crawley JN, Hommer DW, Skirboll LR. Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine. Neurochemistry International. 6: 755-60. PMID 20488104 DOI: 10.1016/0197-0186(84)90007-X  0.313
2011 Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 534-44. PMID 21791566 DOI: 10.1101/Lm.2213711  0.619
2011 Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J. Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions. Autism Research : Official Journal of the International Society For Autism Research. 4: 57-67. PMID 21254450 DOI: 10.1002/Aur.180  0.305
2011 Yang M, Perry K, Weber MD, Katz AM, Crawley JN. Social peers rescue autism-relevant sociability deficits in adolescent mice. Autism Research : Official Journal of the International Society For Autism Research. 4: 17-27. PMID 20928844 DOI: 10.1002/Aur.163  0.604
2011 Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY, Sheng M, Crawley JN. Sociability and motor functions in Shank1 mutant mice. Brain Research. 1380: 120-37. PMID 20868654 DOI: 10.1016/J.Brainres.2010.09.026  0.531
2010 Crawley JN. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease. Exs. 102: 133-41. PMID 21299066 DOI: 10.1007/978-3-0346-0228-0_10  0.345
2010 Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, Yang M, Katz AM, Scattoni ML, Harris MJ, Saxena R, Silverman JL, Crawley JN, Zhou Q, et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Molecular Autism. 1: 15. PMID 21167025 DOI: 10.1186/2040-2392-1-15  0.447
2010 Silverman JL, Yang M, Turner SM, Katz AM, Bell DB, Koenig JI, Crawley JN. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience. 171: 1197-208. PMID 20888890 DOI: 10.1016/J.Neuroscience.2010.09.059  0.643
2009 Scattoni ML, Crawley J, Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neuroscience and Biobehavioral Reviews. 33: 508-15. PMID 18771687 DOI: 10.1016/j.neubiorev.2008.08.003  0.356
2008 Yang M, Weber MD, Crawley JN. Light phase testing of social behaviors: not a problem. Frontiers in Neuroscience. 2: 186-91. PMID 19225591 DOI: 10.3389/neuro.01.029.2008  0.431
2008 Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8709-23. PMID 18753372 DOI: 10.1523/Jneurosci.2077-08.2008  0.654
2008 Crawley JN. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. 65: 1836-41. PMID 18500642 DOI: 10.1007/s00018-008-8158-3  0.344
2008 Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 57: 809-18. PMID 18367082 DOI: 10.1016/j.neuron.2008.03.001  0.317
2008 Scattoni ML, McFarlane HG, Zhodzishsky V, Caldwell HK, Young WS, Ricceri L, Crawley JN. Reduced ultrasonic vocalizations in vasopressin 1b knockout mice. Behavioural Brain Research. 187: 371-8. PMID 18005969 DOI: 10.1016/J.Bbr.2007.09.034  0.373
2008 Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A, Heilig M. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology. 195: 547-57. PMID 17891380 DOI: 10.1007/S00213-007-0945-2  0.48
2008 McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior. 7: 152-63. PMID 17559418 DOI: 10.1111/j.1601-183X.2007.00330.x  0.381
2008 McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like behavioral phenotypes in BTBR T+tf/J mice (Genes, Brain and Behavior (2007) DOI: 10.1111/j. 1601-183X.2007.00330.x) Genes, Brain and Behavior. 7: 163. DOI: 10.1111/j.1601-183X.2007.00355.x  0.337
2008 Yang M, Clarke A, Zhodzishsky V, Crawley J. Autism-like behaviors in BTBR T+tf/J mice are not attributable to early maternal environment or corpus callosum absence International Journal of Developmental Neuroscience. 26: 868. DOI: 10.1016/J.Ijdevneu.2008.09.129  0.352
2007 Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN. Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacology, Biochemistry, and Behavior. 86: 8-20. PMID 17257664 DOI: 10.1016/J.Pbb.2006.11.024  0.346
2007 Ricceri L, Moles A, Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behavioural Brain Research. 176: 40-52. PMID 16996147 DOI: 10.1016/j.bbr.2006.08.024  0.366
2007 He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ. Corrigendum to "ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice" [Neuroscience 133 (2005) 371-380] (DOI:10.1016/j.neuroscience.2005.01.068) Neuroscience. 144: 1544. DOI: 10.1016/J.Neuroscience.2006.12.005  0.356
2005 Rustay NR, Wrenn CC, Kinney JW, Holmes A, Bailey KR, Sullivan TL, Harris AP, Long KC, Saavedra MC, Starosta G, Innerfield CE, Yang RJ, Dreiling JL, Crawley JN. Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides. 39: 239-43. PMID 15944016 DOI: 10.1016/J.Npep.2004.12.026  0.443
2005 He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ. Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice. Neuroscience. 133: 371-80. PMID 15885921 DOI: 10.1016/J.Neuroscience.2005.01.068  0.389
2005 Karlsson RM, Holmes A, Heilig M, Crawley JN. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacology, Biochemistry, and Behavior. 80: 427-36. PMID 15740785 DOI: 10.1016/J.Pbb.2004.12.009  0.482
2005 Holmes A, Li Q, Koenig EA, Gold E, Stephenson D, Yang RJ, Dreiling J, Sullivan T, Crawley JN. Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior. Psychopharmacology. 178: 276-85. PMID 15365683 DOI: 10.1007/s00213-004-1997-1  0.455
2004 Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN. Automated apparatus for quantitation of social approach behaviors in mice. Genes, Brain, and Behavior. 3: 303-14. PMID 15344923 DOI: 10.1111/J.1601-183X.2004.00071.X  0.334
2004 Wrenn CC, Kinney JW, Marriott LK, Holmes A, Harris AP, Saavedra MC, Starosta G, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Wenk GL, Crawley JN. Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. The European Journal of Neuroscience. 19: 1384-96. PMID 15016096 DOI: 10.1111/J.1460-9568.2004.03214.X  0.454
2003 Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes, Brain, and Behavior. 2: 365-80. PMID 14653308 DOI: 10.1046/J.1601-1848.2003.00050.X  0.534
2003 Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry. 54: 953-9. PMID 14625137 DOI: 10.1016/J.Biopsych.2003.09.003  0.424
2003 Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2077-88. PMID 12968128 DOI: 10.1038/sj.npp.1300266  0.466
2003 Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L, Vishwanath J, Saavedra MC, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Crawley JN. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1031-44. PMID 12700679 DOI: 10.1038/Sj.Npp.1300164  0.477
2003 Blakeman KH, Hao JX, Xu XJ, Jacoby AS, Shine J, Crawley JN, Iismaa T, Wiesenfeld-Hallin Z. Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience. 117: 221-7. PMID 12605908 DOI: 10.1016/S0306-4522(02)00779-0  0.339
2002 Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes, Brain, and Behavior. 1: 55-69. PMID 12886950 DOI: 10.1046/J.1601-1848.2001.00005.X  0.527
2002 Wrenn CC, Marriott LK, Kinney JW, Holmes A, Wenk GL, Crawley JN. Galanin peptide levels in hippocampus and cortex of galanin-overexpressing transgenic mice evaluated for cognitive performance. Neuropeptides. 36: 413-26. PMID 12507436 DOI: 10.1016/S0143-4179(02)00111-7  0.528
2002 Holmes A, Yang RJ, Murphy DL, Crawley JN. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 914-23. PMID 12464448 DOI: 10.1016/S0893-133X(02)00374-3  0.47
2002 Kinney JW, Starosta G, Holmes A, Wrenn CC, Yang RJ, Harris AP, Long KC, Crawley JN. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learning & Memory (Cold Spring Harbor, N.Y.). 9: 178-90. PMID 12177231 DOI: 10.1101/M.49502  0.471
2002 Holmes A, Murphy DL, Crawley JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology. 161: 160-7. PMID 11981596 DOI: 10.1007/S00213-002-1024-3  0.439
2002 Holmes A, Yang RJ, Crawley JN. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. Journal of Molecular Neuroscience : Mn. 18: 151-65. PMID 11931346 DOI: 10.1385/JMN:18:1-2:151  0.504
2001 Miyakawa T, Yared E, Pak JH, Huang FL, Huang KP, Crawley JN. Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus. 11: 763-75. PMID 11811671 DOI: 10.1002/hipo.1092  0.328
2001 Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, Crawley JN. Behavioral characterization of dopamine D5 receptor null mutant mice. Behavioral Neuroscience. 115: 1129-44. PMID 11584926 DOI: 10.1037/0735-7044.115.5.1129  0.512
2001 Paylor R, Zhao Y, Libbey M, Westphal H, Crawley JN. Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiology & Behavior. 73: 781-92. PMID 11566211 DOI: 10.1016/S0031-9384(01)00515-7  0.752
2001 Steiner RA, Hohmann JG, Holmes A, Wrenn CC, Cadd G, Juréus A, Clifton DK, Luo M, Gutshall M, Ma SY, Mufson EJ, Crawley JN. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 98: 4184-9. PMID 11259657 DOI: 10.1073/Pnas.061445598  0.455
1999 Crawley JN. The role of galanin in feeding behavior. Neuropeptides. 33: 369-75. PMID 10657514 DOI: 10.1054/npep.1999.0049  0.305
1999 Gleason TC, Dreiling JL, Crawley JN. Rat strain differences in response to galanin on the Morris water task. Neuropeptides. 33: 265-70. PMID 10657502 DOI: 10.1054/npep.1999.0044  0.346
1999 Paylor R, Hirotsune S, Gambello MJ, Yuva-Paylor L, Crawley JN, Wynshaw-Boris A. Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learning & Memory (Cold Spring Harbor, N.Y.). 6: 521-37. PMID 10541472 DOI: 10.1101/Lm.6.5.521  0.317
1998 McDonald MP, Gleason TC, Robinson JK, Crawley JN. Galanin inhibits performance on rodent memory tasks. Annals of the New York Academy of Sciences. 863: 305-22. PMID 9928180 DOI: 10.1111/J.1749-6632.1998.Tb10704.X  0.503
1998 Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L, Crawley JN, Johnson PF. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proceedings of the National Academy of Sciences of the United States of America. 95: 10908-13. PMID 9724803 DOI: 10.1073/Pnas.95.18.10908  0.752
1998 Jänne PA, Suchy SF, Bernard D, MacDonald M, Crawley J, Grinberg A, Wynshaw-Boris A, Westphal H, Nussbaum RL. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. The Journal of Clinical Investigation. 101: 2042-53. PMID 9593760 DOI: 10.1172/Jci2414  0.352
1997 Paylor R, Crawley JN. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology. 132: 169-80. PMID 9266614 DOI: 10.1007/S002130050333  0.328
1997 De Bartolomeis A, Koprivica V, Pickar D, Crawley JN, Abbott LC. Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg). Brain Research. Molecular Brain Research. 46: 321-4. PMID 9191109 DOI: 10.1016/S0169-328X(97)00027-2  0.65
1997 Paylor R, Pickar D, Crawley JN. Characterization of inbred mouse strain differences in startle and the prepulse inhibition model of schizophrenia Schizophrenia Research. 24: 59. DOI: 10.1016/S0920-9964(97)82165-2  0.401
1996 Holmes PV, Crawley JN. Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. Brain Research. Molecular Brain Research. 36: 184-8. PMID 9011757 DOI: 10.1016/0169-328X(95)00295-4  0.511
1996 Robinson JK, Zocchi A, Pert A, Crawley JN. Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus. Brain Research. 709: 81-7. PMID 8869559 DOI: 10.1016/0006-8993(95)01307-5  0.438
1996 König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 383: 535-8. PMID 8849726 DOI: 10.1038/383535A0  0.543
1996 Robinson JK, Wenk GL, Wiley RG, Lappi DA, Crawley JN. 192IgG-Saporin immunotoxin and ibotenic acid lesions of nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats Psychobiology. 24: 179-186. DOI: 10.3758/Bf03327034  0.47
1995 Holmes PV, Blanchard DC, Blanchard RJ, Brady LS, Crawley JN. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacology, Biochemistry, and Behavior. 50: 655-60. PMID 7542391 DOI: 10.1016/0091-3057(94)00334-3  0.524
1995 Holmes PV, de Bartolomeis A, Koprivica V, Crawley JN. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus. Synapse (New York, N.Y.). 19: 197-205. PMID 7540319 DOI: 10.1002/syn.890190307  0.671
1994 Yamanaka S, Johnson MD, Grinberg A, Westphal H, Crawley JN, Taniike M, Suzuki K, Proia RL. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proceedings of the National Academy of Sciences of the United States of America. 91: 9975-9. PMID 7937929 DOI: 10.1073/Pnas.91.21.9975  0.332
1994 de Bartolomeis A, Austin MC, Goodwin GA, Spear LP, Pickar D, Crawley JN. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment. Brain Research. Molecular Brain Research. 21: 321-32. PMID 7909578 DOI: 10.1016/0169-328X(94)90263-1  0.634
1994 Holmes PV, Koprivica V, Chough E, Crawley JN. Intraventricular administration of galanin does not affect behaviors associated with locus coeruleus activation in rats. Peptides. 15: 1303-8. PMID 7531843 DOI: 10.1016/0196-9781(94)90158-9  0.57
1994 Robinson JK, Crawley JN. Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats Behavioral Neuroscience. 108: 941-950. PMID 7530011 DOI: 10.1037/0735-7044.108.5.941  0.461
1993 Drugan RC, Paul SM, Crawley JN. Decreased forebrain [35S]TBPS binding and increased [3H]muscimol binding in rats that do not develop stress-induced behavioral depression. Brain Research. 631: 270-6. PMID 8131055 DOI: 10.1016/0006-8993(93)91545-4  0.629
1993 Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacology, Biochemistry, and Behavior. 46: 967-72. PMID 7906042 DOI: 10.1016/0091-3057(93)90230-Q  0.499
1993 Robinson JK, Crawley JN. Intraventricular Galanin Impairs Delayed Nonmatching-to-Sample Performance in Rats Behavioral Neuroscience. 107: 458-467. PMID 7687133 DOI: 10.1037//0735-7044.107.3.458  0.467
1993 Crawley JN, Robinson JK, Langel U, Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding Brain Research. 600: 268-272. PMID 7679604 DOI: 10.1016/0006-8993(93)91382-3  0.457
1993 Robinson JK, Crawley JN. The role of galanin in cholinergically-mediated memory processes Progress in Neuropsychopharmacology and Biological Psychiatry. 17: 71-85. PMID 7677976 DOI: 10.1016/0278-5846(93)90033-O  0.463
1993 Corwin RL, Robinson JK, Crawley JN. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. The European Journal of Neuroscience. 5: 1528-33. PMID 7506975 DOI: 10.1111/J.1460-9568.1993.Tb00221.X  0.512
1993 Robinson JK, Crawley JN. Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample Journal of Neuroscience. 13: 5119-5125. PMID 7504722 DOI: 10.1523/Jneurosci.13-12-05119.1993  0.472
1993 Stivers JA, Kaltwasser MT, Hill PS, Hruby VJ, Crawley JN. Ventral tegmental oxytocin induces grooming. Peptides. 223-31. PMID 2856647 DOI: 10.1016/0196-9781(88)90248-3  0.366
1991 Jaskiw GE, Weinberger DR, Crawley JN. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biological Psychiatry. 29: 703-6. PMID 1711381 DOI: 10.1016/0006-3223(91)90144-B  0.315
1990 Fisone G, Berthold M, Bedecs K, Undén A, Bartfai T, Bertorelli R, Consolo S, Crawley J, Martin B, Nilsson S. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proceedings of the National Academy of Sciences of the United States of America. 86: 9588-91. PMID 2594786 DOI: 10.1073/Pnas.86.23.9588  0.308
1990 Dauge V, Bohme GA, Crawley JN, Durieux C, Stutzmann JM, Feger J, Blanchard JC, Roques BP. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. Synapse (New York, N.Y.). 6: 73-80. PMID 2399491 DOI: 10.1002/Syn.890060109  0.361
1990 Cottingham SL, Pickar D, Shimotake TK, Montpied P, Paul SM, Crawley JN. Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration. Cellular and Molecular Neurobiology. 10: 41-50. PMID 1970757 DOI: 10.1007/Bf00733634  0.453
1990 Crawley J, Austin M, Fiske S, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus The Journal of Neuroscience. 10: 3695-3700. DOI: 10.1523/Jneurosci.10-11-03695.1990  0.332
1989 Drugan RC, Skolnick P, Paul SM, Crawley JN. A pretest procedure reliably predicts performance in two animal models of inescapable stress. Pharmacology, Biochemistry, and Behavior. 33: 649-54. PMID 2587607 DOI: 10.1016/0091-3057(89)90403-6  0.633
1989 Mastropaolo J, Nadi NS, Ostrowski NL, Crawley JN. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proceedings of the National Academy of Sciences of the United States of America. 85: 9841-5. PMID 2462255 DOI: 10.1073/PNAS.85.24.9841  0.346
1988 Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Characterization of stress-induced alterations in [3H] Ro5-4864 binding to peripheral benzodiazepine receptors in rat heart and kidney. Pharmacology, Biochemistry, and Behavior. 30: 1015-20. PMID 2852369 DOI: 10.1016/0091-3057(88)90134-7  0.609
1988 Moody TW, Merali Z, Crawley JN. The effects of anxiolytics and other agents on rat grooming behavior Annals of the New York Academy of Sciences. 525: 281-290. PMID 2455462 DOI: 10.1111/J.1749-6632.1988.Tb38613.X  0.326
1987 Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. "Peripheral" benzodiazepine binding sites in the Maudsley reactive rat: selective decrease confined to peripheral tissues. Brain Research Bulletin. 18: 143-5. PMID 3030509 DOI: 10.1016/0361-9230(87)90044-X  0.607
1987 Drugan RC, Crawley JN, Paul SM, Skolnick P. Buspirone attenuates learned helplessness behavior in rats Drug Development Research. 10: 63-67. DOI: 10.1002/DDR.430100204  0.63
1986 Bolger GT, Rafferty MF, Crawley JN, Paul SM, Skolnick P. Effects of calcium antagonists on phencyclidine behaviors. Pharmacology, Biochemistry, and Behavior. 25: 45-9. PMID 3749237 DOI: 10.1016/0091-3057(86)90228-5  0.325
1986 Wolkowitz O, Sutton M, Koulo M, Labarca R, Wilkinson L, Doran A, Hauger R, Pickar D, Crawley J. Chronic corticosterone administration in rats: Behavioral and biochemical evidence of increased central dopaminergic activity European Journal of Pharmacology. 122: 329-338. PMID 3709658 DOI: 10.1016/0014-2999(86)90413-9  0.559
1986 Drugan RC, Skolnick P, Paul SM, Crawley JN. Low doses of muscimol produce anticonflict actions in the lateral septum of the rat. Neuropharmacology. 25: 203-5. PMID 3703171 DOI: 10.1016/0028-3908(86)90042-0  0.606
1986 Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P. Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheral-type" benzodiazepine receptors in the rat. Pharmacology, Biochemistry, and Behavior. 24: 1673-7. PMID 3016760 DOI: 10.1016/0091-3057(86)90504-6  0.599
1986 Hommer D, Stoner G, Crawley J, Paul S, Skirboll L. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype The Journal of Neuroscience. 6: 3039-3043. DOI: 10.1523/Jneurosci.06-10-03039.1986  0.309
1986 Skirboll LR, Crawley J, Hommer DW. Chapter 25 Functional studies of cholecystokinin-dopamine coexistence: electrophysiology and behavior Progress in Brain Research. 68: 357-370. DOI: 10.1016/S0079-6123(08)60251-4  0.341
1985 Crawley JN, Kiss JZ, Mezey E. Bilateral midbrain transections block the behavioral effects of cholecystokinin on feeding and exploration in rats. Brain Research. 322: 316-21. PMID 6509319 DOI: 10.1016/0006-8993(84)90124-0  0.336
1985 Hommer DW, Pickar D, Crawley JN, Weingartner H, Paul SM. The effects of cholecystokinin-like peptides in schizophrenics and normal human subjects. Annals of the New York Academy of Sciences. 448: 542-52. PMID 3896099 DOI: 10.1111/J.1749-6632.1985.Tb29947.X  0.439
1985 Drugan RC, Maier SF, Skolnick P, Paul SM, Crawley JN. An anxiogenic benzodiazepine receptor ligand induces learned helplessness. European Journal of Pharmacology. 113: 453-7. PMID 2995072 DOI: 10.1016/0014-2999(85)90096-2  0.629
1985 Crawley JN, Sutton ME, Pickar D. Animal models of self-destructive behavior and suicide Psychiatric Clinics of North America. 8: 299-310. PMID 2410895 DOI: 10.1016/S0193-953X(18)30696-8  0.517
1985 Crawley J, Stivers J, Blumstein L, Paul S. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence The Journal of Neuroscience. 5: 1972-1983. DOI: 10.1523/JNEUROSCI.05-08-01972.1985  0.333
1985 Hommer D, Palkovits M, Crawley J, Paul S, Skirboll L. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components The Journal of Neuroscience. 5: 1387-1392. DOI: 10.1523/Jneurosci.05-06-01387.1985  0.313
1985 Crawley J, Ninan P, Pickar D, Chrousos G, Linnoila M, Skolnick P, Paul S. Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys The Journal of Neuroscience. 5: 477-485. DOI: 10.1523/Jneurosci.05-02-00477.1985  0.504
1984 Crawley JN, Schwaber JS. Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius Brain Research. 295: 289-299. PMID 6713189 DOI: 10.1016/0006-8993(84)90978-8  0.345
1984 Crawley JN. Cholecystokinin accelerates the rate of habituation to a novel environment Pharmacology, Biochemistry and Behavior. 20: 23-27. PMID 6320229 DOI: 10.1016/0091-3057(84)90094-7  0.368
1984 Skolnick P, Ninan P, Insel T, Crawley J, Paul S. A novel chemically induced animal model of human anxiety. Psychopathology. 25-36. PMID 6143342 DOI: 10.1159/000284074  0.324
1983 Blumstein LK, Crawley JN. Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines Pharmacology, Biochemistry and Behavior. 18: 37-40. PMID 6828535 DOI: 10.1016/0091-3057(83)90247-2  0.348
1983 Crawley JN, Schwaber JS. Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin Peptides. 4: 743-747. PMID 6318204 DOI: 10.1016/0196-9781(83)90030-X  0.34
1983 Crawley JN. Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors Peptides. 4: 405-410. PMID 6316290 DOI: 10.1016/0196-9781(83)90040-2  0.316
1983 Crawley JN, Patel J, Marangos PJ. Adenosine uptake inhibitors potentiate the sedative effects of adenosine. Neuroscience Letters. 36: 169-74. PMID 6306520 DOI: 10.1016/0304-3940(83)90260-4  0.348
1983 Crawley JN, Moody TW. Anxiolytics block excessive grooming behavior induced by ACTH1-24 and bombesin Brain Research Bulletin. 10: 399-401. PMID 6303524 DOI: 10.1016/0361-9230(83)90111-9  0.344
1982 Crawley JN, Szara S, Pryor GT, Creveling CR, Bernard BK. Development and evaluation of a computer-automated color TV tracking system for automatic recording of the social and exploratory behavior of small animals. Journal of Neuroscience Methods. 5: 235-47. PMID 7078256 DOI: 10.1016/0165-0270(82)90074-7  0.318
1982 Crawley JN, Davis LG. Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains Brain Research Bulletin. 8: 609-612. PMID 6890398 DOI: 10.1016/0361-9230(82)90087-9  0.353
1982 Crawley JN, Marangos PJ, Stivers J, Goodwin FK. Chronic clonazepam administration induces benzodiazepine receptor subsensitivity. Neuropharmacology. 21: 85-9. PMID 6278355 DOI: 10.1016/0028-3908(82)90216-7  0.335
1982 Marangos PJ, Crawley JN. Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain Neuropharmacology. 21: 81-84. PMID 6278354 DOI: 10.1016/0028-3908(82)90215-5  0.301
1981 Crawley JN, Hays SE, O'Donohue TL, Paul SM, Goodwin FK. Neuropeptide modulation of social and exploratory behaviors in laboratory rodents. Peptides. 2: 123-9. PMID 7267400 DOI: 10.1016/0196-9781(81)90066-8  0.374
1981 Crawley JN, Marangos PJ, Paul SM, Skolnick P, Goodwin FK. Interaction between purine and benzodiazepine: Inosine reverses diazepam-induced stimulation of mouse exploratory behavior. Science (New York, N.Y.). 211: 725-7. PMID 6256859 DOI: 10.1126/Science.6256859  0.388
1980 Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacology, Biochemistry, and Behavior. 13: 167-70. PMID 6106204 DOI: 10.1016/0091-3057(80)90067-2  0.399
1976 Crawley JN, Contrera JF. Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice Pharmacology, Biochemistry and Behavior. 4: 381-384. PMID 945581 DOI: 10.1016/0091-3057(76)90051-4  0.385
Low-probability matches (unlikely to be authored by this person)
1980 Crawley JN, Maas JW, Roth RH. Biochemical evidence for simultaneous activation of multiple locus coeruleus efferents. Life Sciences. 26: 1373-8. PMID 6991843 DOI: 10.1016/0024-3205(80)90039-9  0.3
1997 Crawley JN, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behavior. 31: 197-211. PMID 9213134 DOI: 10.1006/hbeh.1997.1382  0.3
1983 Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin [15] Nature. 302: 703-706. PMID 6300693 DOI: 10.1038/302703a0  0.299
1991 Schultzberg M, Austin MC, Crawley JN, Paul SM. Repeated administration of desmethylimipramine blocks the reserpine-induced increase in tyrosine hydroxylase mRNA in locus coeruleus neurons of the rat Molecular Brain Research. 10: 307-314. PMID 1717808 DOI: 10.1016/0169-328X(91)90089-G  0.298
2018 Van de Water J, Jones KL, Silverman J, Yang M, Crawley J. T49. Autism-Specific Maternal Autoantibodies Produce ASD Relevant Behaviors in a Mouse Model Biological Psychiatry. 83: S147-S148. DOI: 10.1016/j.biopsych.2018.02.385  0.297
1999 Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research. 835: 18-26. PMID 10448192 DOI: 10.1016/S0006-8993(98)01258-X  0.293
1999 Davis JA, Paylor R, McDonald MP, Libbey M, Ligler A, Bryant K, Crawley JN. Behavioral effects of ivermectin in mice. Laboratory Animal Science. 49: 288-96. PMID 10403444  0.292
2014 Kas MJ, Glennon JC, Buitelaar J, Ey E, Biemans B, Crawley J, Ring RH, Lajonchere C, Esclassan F, Talpos J, Noldus LP, Burbach JP, Steckler T. Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives. Psychopharmacology. 231: 1125-46. PMID 24048469 DOI: 10.1007/S00213-013-3268-5  0.289
1990 Consolo S, Palazzi E, Bertorelli R, Fisone G, Crawley J, Hokfelt T, Bartfai T. Functional aspects of acetylcholine-galanin coexistence in the brain. Progress in Brain Research. 84: 279-287. PMID 1702545 DOI: 10.1016/S0079-6123(08)60912-7  0.288
1988 Stivers JA, Skirboll LR, Long R, Crawley JN. Anatomical analysis of frontal cortex sites at which carbachol induces motor seizures in the rat. Pharmacology, Biochemistry, and Behavior. 30: 129-36. PMID 3174734 DOI: 10.1016/0091-3057(88)90435-2  0.288
2015 Flannery BM, Silverman JL, Bruun DA, Puhger KR, McCoy MR, Hammock BD, Crawley JN, Lein PJ. Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine. Neurotoxicology and Teratology. 47: 36-45. PMID 25446016 DOI: 10.1016/J.Ntt.2014.10.008  0.286
1982 Moody TW, Crawley JN, Jensen RT. Pharmacology and neurochemistry of bombesin-like peptides Peptides. 3: 559-563. PMID 6181494 DOI: 10.1016/0196-9781(82)90126-7  0.286
1984 Crawley JN, Skolnic P, Paul SM. Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse Neuropharmacology. 23: 531-537. PMID 6146107 DOI: 10.1016/0028-3908(84)90026-1  0.284
1983 Skolnick P, Paul S, Crawley J, Lewin E, Lippa A, Clody D, Irmscher K, Saiko O, Minck KO. Antagonism of the anxiolytic action of diazepam and chlordiazepoxide by the novel imidazopyridines, EMD 39593 and EMD 41717. European Journal of Pharmacology. 88: 319-27. PMID 6688050 DOI: 10.1016/0014-2999(83)90582-4  0.282
2014 Brielmaier J, Senerth JM, Silverman JL, Matteson PG, Millonig JH, DiCicco-Bloom E, Crawley JN. Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes, Brain, and Behavior. 13: 286-298. PMID 24730055 DOI: 10.1111/Gbb.12115  0.282
2013 Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN. Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. Neuropharmacology. 68: 210-22. PMID 22968082 DOI: 10.1016/J.Neuropharm.2012.07.042  0.28
1988 Glowa JR, Crawley J, Suzdak PD, Paul SM. Ethanol and the GABA receptor complex: Studies with the partial inverse benzodiazepine receptor agonist Ro 15-4513 Pharmacology, Biochemistry and Behavior. 31: 767-772. PMID 2855121 DOI: 10.1016/0091-3057(88)90263-8  0.28
1994 Mathis C, Paul SM, Crawley JN. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice Behavior Genetics. 24: 171-180. PMID 8024534 DOI: 10.1007/BF01067821  0.278
2017 Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews. Drug Discovery. PMID 29217836 DOI: 10.1038/nrd.2017.221  0.278
1992 Leppin C, Finiels-Marlier F, Crawley JN, Montpied P, Paul SM. Failure of a protein synthesis inhibitor to modify glutamate receptor-mediated neurotoxicity in vivo. Brain Research. 581: 168-70. PMID 1379868 DOI: 10.1016/0006-8993(92)90359-H  0.278
1980 Crawley JN, Maas JW, Roth RH. Evidence against specificity of electrical stimulation of the nucleus locus coeruleus in activating the sympathetic nervous system in the rat. Brain Research. 183: 301-11. PMID 7353141 DOI: 10.1016/0006-8993(80)90466-7  0.277
1981 Crawley JN, Hays SE, Paul SM, Goodwin FK. Cholecystokinin reduces exploratory behavior in mice. Physiology & Behavior. 27: 407-11. PMID 6278520 DOI: 10.1016/0031-9384(81)90324-3  0.277
2009 Yang M, Clarke AM, Crawley JN. Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability. The European Journal of Neuroscience. 29: 1663-77. PMID 19419429 DOI: 10.1111/j.1460-9568.2009.06714.x  0.277
1998 Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learning & Memory (Cold Spring Harbor, N.Y.). 5: 302-16. PMID 10454356  0.276
2004 Crawley JN. Designing mouse behavioral tasks relevant to autistic-like behaviors. Mental Retardation and Developmental Disabilities Research Reviews. 10: 248-58. PMID 15666335 DOI: 10.1002/mrdd.20039  0.274
2023 Gundersen BB, O'Brien WT, Schaffler MD, Schultz MN, Tsukahara T, Lorenzo SM, Nalesso V, Luo Clayton AH, Abel T, Crawley JN, Datta SR, Herault Y. Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion Syndrome. Biorxiv : the Preprint Server For Biology. PMID 37745360 DOI: 10.1101/2023.05.01.538987  0.274
2002 Crawley JN, Mufson EJ, Hohmann JG, Teklemichael D, Steiner RA, Holmberg K, Xu ZQ, Blakeman KH, Xu XJ, Wiesenfeld-Hallin Z, Bartfai T, Hökfelt T. Galanin overexpressing transgenic mice. Neuropeptides. 36: 145-56. PMID 12359505 DOI: 10.1054/Npep.2002.0891  0.273
2007 Crawley JN. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathology (Zurich, Switzerland). 17: 448-59. PMID 17919130 DOI: 10.1111/j.1750-3639.2007.00096.x  0.273
2008 Moy SS, Nadler JJ, Young NB, Nonneman RJ, Segall SK, Andrade GM, Crawley JN, Magnuson TR. Social approach and repetitive behavior in eleven inbred mouse strains. Behavioural Brain Research. 191: 118-29. PMID 18440079 DOI: 10.1016/J.Bbr.2008.03.015  0.273
2019 Dutta R, Crawley JN. Behavioral Evaluation of Angelman Syndrome Mice at Older Ages. Neuroscience. PMID 31730795 DOI: 10.1016/j.neuroscience.2019.10.027  0.27
2019 Rhine MA, Parrott JM, Schultz MN, Kazdoba TM, Crawley JN. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism. Autism Research : Official Journal of the International Society For Autism Research. PMID 30653853 DOI: 10.1002/aur.2066  0.27
1984 Skolnick P, Crawley JN, Glowa JR, Paul SM. β-Carboline-induced anxiety states Psychopathology. 17: 52-60. PMID 6505120 DOI: 10.1159/000284131  0.27
2010 Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS. Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behavioural Brain Research. 208: 178-88. PMID 19941908 DOI: 10.1016/j.bbr.2009.11.031  0.27
2011 Wöhr M, Roullet FI, Hung AY, Sheng M, Crawley JN. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. Plos One. 6: e20631. PMID 21695253 DOI: 10.1371/Journal.Pone.0020631  0.267
2013 Kerr TM, Muller CL, Miah M, Jetter CS, Pfeiffer R, Shah C, Baganz N, Anderson GM, Crawley JN, Sutcliffe JS, Blakely RD, Veenstra-Vanderweele J. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Molecular Autism. 4: 35. PMID 24083388 DOI: 10.1186/2040-2392-4-35  0.267
1975 Crawley JN, Schleidt WM, Contrera JF. Does social environment decrease propensity to fight in male mice? Behavioral Biology. 15: 73-83. PMID 1237289 DOI: 10.1016/S0091-6773(75)92105-7  0.266
1997 Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell. 90: 895-905. PMID 9298901 DOI: 10.1016/S0092-8674(00)80354-2  0.266
2008 Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H. Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiology of Disease. 29: 505-14. PMID 18187333 DOI: 10.1016/J.Nbd.2007.11.011  0.266
2008 Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behavioural Brain Research. 188: 178-94. PMID 18068825 DOI: 10.1016/J.Bbr.2007.10.029  0.265
1986 Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat Science. 234: 1243-1247. PMID 3022383 DOI: 10.1126/Science.3022383  0.265
2006 Crawley JN. What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice: Second Edition What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice: Second Edition. 1-523. DOI: 10.1002/9780470119051  0.264
1985 Crawley JN. Exploratory behavior models of anxiety in mice Neuroscience and Biobehavioral Reviews. 9: 37-44. PMID 2858080 DOI: 10.1016/0149-7634(85)90030-2  0.264
2008 Stack CM, Lim MA, Cuasay K, Stone MM, Seibert KM, Spivak-Pohis I, Crawley JN, Waschek JA, Hill JM. Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice. Experimental Neurology. 211: 67-84. PMID 18316078 DOI: 10.1016/J.Expneurol.2008.01.003  0.263
2010 Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G, Chen G, Crawley JN, Manji HK. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biological Psychiatry. 67: 864-71. PMID 20034613 DOI: 10.1016/J.Biopsych.2009.10.018  0.263
2006 Wrenn CC, Turchi JN, Schlosser S, Dreiling JL, Stephenson DA, Crawley JN. Performance of galanin transgenic mice in the 5-choice serial reaction time attentional task. Pharmacology, Biochemistry, and Behavior. 83: 428-40. PMID 16626795 DOI: 10.1016/j.pbb.2006.03.003  0.262
1990 Laitinen K, Crawley JN, Mefford IN, De Witte P. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Research. 523: 342-6. PMID 1698106 DOI: 10.1016/0006-8993(90)91511-E  0.261
2009 Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL, D'Ercole AJ, Crawley JN, Magnuson TR, Lauder JM. Social approach in genetically engineered mouse lines relevant to autism. Genes, Brain, and Behavior. 8: 129-42. PMID 19016890 DOI: 10.1111/J.1601-183X.2008.00452.X  0.261
2008 Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N, Crawley JN. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Research : Official Journal of the International Society For Autism Research. 1: 147-58. PMID 19360662 DOI: 10.1002/Aur.22  0.261
1998 McDonald MP, Wong R, Goldstein G, Weintraub B, Cheng SY, Crawley JN. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learning & Memory (Cold Spring Harbor, N.Y.). 5: 289-301. PMID 10454355  0.26
2015 Daimon CM, Jasien JM, Wood WH, Zhang Y, Becker KG, Silverman JL, Crawley JN, Martin B, Maudsley S. Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder. Frontiers in Physiology. 6: 324. PMID 26635614 DOI: 10.3389/Fphys.2015.00324  0.259
2013 Babineau BA, Yang M, Berman RF, Crawley JN. Low home cage social behaviors in BTBR T+tf/J mice during juvenile development. Physiology & Behavior. 114: 49-54. PMID 23510981 DOI: 10.1016/J.Physbeh.2013.03.006  0.258
2006 Bailey KR, Rustay NR, Crawley JN. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 47: 124-31. PMID 16547369  0.256
2004 Laplante F, Crawley JN, Quirion R. Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regulatory Peptides. 122: 91-8. PMID 15380926 DOI: 10.1016/J.Regpep.2004.05.022  0.256
2020 Schultz MN, Crawley JN. Evaluation of a TrkB agonist on spatial and motor learning in the mouse model of Angelman syndrome. Learning & Memory (Cold Spring Harbor, N.Y.). 27: 346-354. PMID 32817301 DOI: 10.1101/lm.051201.119  0.253
2010 Schorscher-Petcu A, Sotocinal S, Ciura S, Dupré A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ, Tribollet E, Quirion R, Mogil JS. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8274-84. PMID 20554879 DOI: 10.1523/Jneurosci.1594-10.2010  0.251
1982 Crawley JN, Rojas-Ramirez JA, Mendelson WB. The role of central and peripheral cholecystokinin in mediating appetitive behaviors. Peptides. 3: 535-8. PMID 6289285 DOI: 10.1016/0196-9781(82)90122-X  0.249
2015 Yang M, Lewis F, Foley G, Crawley JN. In Tribute to Bob Blanchard: Divergent Behavioral Phenotypes of 16p11.2 Deletion Mice Reared in Same-Genotype Versus Mixed-Genotype Cages. Physiology & Behavior. PMID 26066718 DOI: 10.1016/j.physbeh.2015.04.023  0.249
2003 Wrenn CC, Harris AP, Saavedra MC, Crawley JN. Social transmission of food preference in mice: methodology and application to galanin-overexpressing transgenic mice. Behavioral Neuroscience. 117: 21-31. PMID 12619904  0.247
2007 Crawley JN, Chen T, Puri A, Washburn R, Sullivan TL, Hill JM, Young NB, Nadler JJ, Moy SS, Young LJ, Caldwell HK, Young WS. Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides. 41: 145-63. PMID 17420046 DOI: 10.1016/J.Npep.2007.02.002  0.247
2007 Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behavioural Brain Research. 176: 4-20. PMID 16971002 DOI: 10.1016/J.Bbr.2006.07.030  0.247
1995 Corwin RL, Rowe PM, Crawley JN. Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. The American Journal of Physiology. 269: R511-8. PMID 7573550 DOI: 10.1152/Ajpregu.1995.269.3.R511  0.246
2014 Portmann T, Yang M, Mao R, Panagiotakos G, Ellegood J, Dolen G, Bader PL, Grueter BA, Goold C, Fisher E, Clifford K, Rengarajan P, Kalikhman D, Loureiro D, Saw NL, ... ... Crawley JN, et al. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Reports. 7: 1077-92. PMID 24794428 DOI: 10.1016/J.Celrep.2014.03.036  0.246
2004 Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes, Brain, and Behavior. 3: 287-302. PMID 15344922 DOI: 10.1111/J.1601-1848.2004.00076.X  0.245
2016 Leach PT, Hayes J, Pride M, Silverman JL, Crawley JN. Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task. Eneuro. 3. PMID 27022628 DOI: 10.1523/ENEURO.0143-15.2016  0.243
2017 Gompers AL, Su-Feher L, Ellegood J, Copping NA, Riyadh MA, Stradleigh TW, Pride MC, Schaffler MD, Wade AA, Catta-Preta R, Zdilar I, Louis S, Kaushik G, Mannion BJ, Plajzer-Frick I, ... ... Crawley JN, et al. Germline Chd8 haploinsufficiency alters brain development in mouse. Nature Neuroscience. PMID 28671691 DOI: 10.1038/Nn.4592  0.243
1979 Crawley JN, Roth RH, Maas JW. Locus coeruleus stimulation increases noradrenergic metabolite levels in rat spinal cord. Brain Research. 166: 180-4. PMID 421150 DOI: 10.1016/0006-8993(79)90661-9  0.24
1997 Liu Y, Hoffmann A, Grinberg A, Westphal H, McDonald MP, Miller KM, Crawley JN, Sandhoff K, Suzuki K, Proia RL. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proceedings of the National Academy of Sciences of the United States of America. 94: 8138-43. PMID 9223328 DOI: 10.1073/Pnas.94.15.8138  0.239
2003 Crawley JN. Behavioral phenotyping of rodents. Comparative Medicine. 53: 140-6. PMID 12784847  0.238
2008 Bainbridge NK, Koselke LR, Jeon J, Bailey KR, Wess J, Crawley JN, Wrenn CC. Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtype. Behavioural Brain Research. 190: 50-8. PMID 18346798 DOI: 10.1016/j.bbr.2008.02.001  0.237
2015 Kazdoba TM, Leach PT, Crawley JN. Behavioral phenotypes of genetic mouse models of autism. Genes, Brain, and Behavior. PMID 26403076 DOI: 10.1111/gbb.12256  0.237
1984 Charlton CG, Miller RL, Crawley JN, Handelmann GE, O'Donohue TL. Secretin modulation of behavioral and physiological functions in the rat. Peptides. 4: 739-42. PMID 6657519 DOI: 10.1016/0196-9781(83)90029-3  0.237
2001 McDonald MP, Miller KM, Li C, Deng C, Crawley JN. Motor deficits in fibroblast growth factor receptor-3 null mutant mice. Behavioural Pharmacology. 12: 477-86. PMID 11742142 DOI: 10.1097/00008877-200111000-00009  0.236
2006 Nadler JJ, Zou F, Huang H, Moy SS, Lauder J, Crawley JN, Threadgill DW, Wright FA, Magnuson TR. Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype. Genetics. 174: 1229-36. PMID 16980393 DOI: 10.1534/Genetics.106.061481  0.235
2010 Silverman JL, Tolu SS, Barkan CL, Crawley JN. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 976-89. PMID 20032969 DOI: 10.1038/npp.2009.201  0.235
2015 Genestine M, Lin L, Durens M, Yan Y, Jiang Y, Prem S, Bailoor K, Kelly B, Sonsalla PK, Matteson PG, Silverman J, Crawley JN, Millonig JH, DiCicco-Bloom E. Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. Human Molecular Genetics. PMID 26220976 DOI: 10.1093/Hmg/Ddv301  0.235
2001 Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandhoff K, Proia RL. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. The Journal of Biological Chemistry. 276: 6885-8. PMID 11133999 DOI: 10.1074/Jbc.C000847200  0.235
2017 Vogel Ciernia A, Pride M, Durbin-Johnson B, Noronha A, Chang A, Yasui DH, Crawley JN, LaSalle JM. Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering. Human Molecular Genetics. PMID 28334953 DOI: 10.1093/hmg/ddx087  0.233
1997 Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132: 107-24. PMID 9266608 DOI: 10.1007/S002130050327  0.233
2005 Wiesenfeld-Hallin Z, Xu XJ, Crawley JN, Hökfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides. 39: 207-10. PMID 15944013 DOI: 10.1016/j.npep.2004.12.017  0.232
2015 Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, et al. 3D visualization of the regional differences. Molecular Psychiatry. 20: 1. PMID 25648202 DOI: 10.1038/Mp.2014.168  0.231
2017 Dhamne SC, Silverman JL, Super CE, Lammers SHT, Hameed MQ, Modi ME, Copping NA, Pride MC, Smith DG, Rotenberg A, Crawley JN, Sahin M. Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Molecular Autism. 8: 26. PMID 28638591 DOI: 10.1186/S13229-017-0142-Z  0.23
1994 Mathis C, Paul SM, Crawley JN. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology. 116: 201-6. PMID 7862949 DOI: 10.1007/BF02245063  0.229
1992 Austin MC, Schultzberg M, Abbott LC, Montpied P, Evers JR, Paul SM, Crawley JN. Expression of tyrosine hydroxylase in cerebellar Purkinje neurons of the mutant tottering and leaner mouse Molecular Brain Research. 15: 227-240. PMID 1279353 DOI: 10.1016/0169-328X(92)90113-P  0.228
2021 Bruce MR, Jones KL, Vernon AC, Silverman JL, Crawley JN, Ellegood J, Lerch JP, Van de Water J. Sexually dimorphic neuroanatomical differences relate to ASD-relevant behavioral outcomes in a maternal autoantibody mouse model. Molecular Psychiatry. PMID 34290368 DOI: 10.1038/s41380-021-01215-w  0.226
2011 Roullet FI, Crawley JN. Mouse models of autism: testing hypotheses about molecular mechanisms. Current Topics in Behavioral Neurosciences. 7: 187-212. PMID 21225409 DOI: 10.1007/7854_2010_113  0.226
2004 Hygge-Blakeman K, Brumovsky P, Hao JX, Xu XJ, Hökfelt T, Crawley JN, Wiesenfeld-Hallin Z. Galanin over-expression decreases the development of neuropathic pain-like behaviors in mice after partial sciatic nerve injury. Brain Research. 1025: 152-8. PMID 15464755 DOI: 10.1016/j.brainres.2004.07.078  0.225
2001 Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. Cns Drug Reviews. 7: 445-70. PMID 11830760 DOI: 10.1111/J.1527-3458.2001.Tb00210.X  0.225
2015 Yang M, Lewis FC, Sarvi MS, Foley GM, Crawley JN. 16p11.2 Deletion mice display cognitive deficits in touchscreen learning and novelty recognition tasks. Learning & Memory (Cold Spring Harbor, N.Y.). 22: 622-32. PMID 26572653 DOI: 10.1101/lm.039602.115  0.225
1996 Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86: 159-71. PMID 8689683 DOI: 10.1016/S0092-8674(00)80086-0  0.224
2013 Ellegood J, Babineau BA, Henkelman RM, Lerch JP, Crawley JN. Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging. Neuroimage. 70: 288-300. PMID 23275046 DOI: 10.1016/J.Neuroimage.2012.12.029  0.222
2014 Kazdoba TM, Leach PT, Silverman JL, Crawley JN. Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable & Rare Diseases Research. 3: 118-33. PMID 25606362 DOI: 10.5582/irdr.2014.01024  0.222
1981 Crawley JN, Hays SE, Paul SM. Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors European Journal of Pharmacology. 73: 379-380. DOI: 10.1016/0014-2999(81)90244-2  0.221
2001 Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 410: 207-12. PMID 11242080 DOI: 10.1038/35065604  0.22
2003 Grass S, Crawley JN, Xu XJ, Wiesenfeld-Hallin Z. Reduced spinal cord sensitization to C-fibre stimulation in mice over-expressing galanin. The European Journal of Neuroscience. 17: 1829-32. PMID 12752782 DOI: 10.1046/j.1460-9568.2003.02623.x  0.219
2017 Sukoff Rizzo SJ, Crawley JN. Behavioral Phenotyping Assays for Genetic Mouse Models of Neurodevelopmental, Neurodegenerative, and Psychiatric Disorders. Annual Review of Animal Biosciences. 5: 371-389. PMID 28199172 DOI: 10.1146/annurev-animal-022516-022754  0.215
1978 Crawley JN, Hattox SE, Maas JW, Roth RH. 3-Methoxy-4-hydroxyphenethyleneglycol increase in plasma after stimulation of the nucleus locus coeruleus. Brain Research. 141: 380-4. PMID 626910 DOI: 10.1016/0006-8993(78)90210-X  0.215
1992 Crawley JN, Evers JR, Paul SM. Polyamines inhibit N-methyl-d-aspartate antagonist-induced darting behavior in the rat prefrontal cortex Brain Research. 586: 6-11. PMID 1511351 DOI: 10.1016/0006-8993(92)91364-K  0.214
1992 Givens BS, Olton DS, Crawley JN. Galanin in the medial septal area impairs working memory. Brain Research. 582: 71-7. PMID 1379875 DOI: 10.1016/0006-8993(92)90318-4  0.214
2006 Moy SS, Nadler JJ, Magnuson TR, Crawley JN. Mouse models of autism spectrum disorders: the challenge for behavioral genetics. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 142: 40-51. PMID 16419099 DOI: 10.1002/Ajmg.C.30081  0.214
2017 Leach PT, Crawley JN. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain, and Behavior. PMID 29266714 DOI: 10.1111/gbb.12452  0.214
2015 Ellegood J, Crawley JN. Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 521-33. PMID 26036957 DOI: 10.1007/s13311-015-0360-z  0.212
1984 Pohl R, Rainey JM, Gershon S, Enna SJ, Skolnick P, Ninan P, Insel T, Crawley J, Paul S, Eison MS, Goldberg HL, Gittelman R, Klein DF, Freedman RR, Ianni P, et al. CME Monograph Tests Psychopathology. 17: 107-117. DOI: 10.1159/000284083  0.211
1988 Kaltwasser MT, Crawley JN. Oxytocin and cholecystokinin induce grooming behavior in the ventral tegmentum of the rat. Brain Research. 426: 1-7. PMID 3690307 DOI: 10.1016/0006-8993(87)90418-5  0.211
2012 Kaltwasser MT, Petrack B, Crawley JN. Potency of CR 1409, a new proglumide analog, on cholecystokinin-mediated behaviors and receptor binding. Neurochemistry International. 10: 547-53. PMID 20501129 DOI: 10.1016/0197-0186(87)90083-0  0.21
2006 DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ. The developmental neurobiology of autism spectrum disorder. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6897-906. PMID 16807320 DOI: 10.1523/Jneurosci.1712-06.2006  0.21
2012 Crawley JN. Translational animal models of autism and neurodevelopmental disorders. Dialogues in Clinical Neuroscience. 14: 293-305. PMID 23226954  0.21
1981 Skolinick P, Paul S, Crawley J, Rice K, Barker S, Weber R, Cain M, Cook J. 3-hydroxymethyl-beta-carboline antagonizes some pharmacologic actions of diazepam. European Journal of Pharmacology. 69: 525-7. PMID 6265233 DOI: 10.1016/0014-2999(81)90462-3  0.209
1985 Crawley JN. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens Annals of the New York Academy of Sciences. 283-292. PMID 3861122 DOI: 10.1111/j.1749-6632.1985.tb29924.x  0.207
2016 Kazdoba TM, Leach PT, Yang M, Silverman JL, Solomon M, Crawley JN. Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics. Current Topics in Behavioral Neurosciences. PMID 27305922 DOI: 10.1007/7854_2015_5003  0.207
1985 Crawley JN, Kiss JZ. Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin Peptides. 6: 927-935. PMID 4080609 DOI: 10.1016/0196-9781(85)90324-9  0.207
1996 Crawley JN. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sciences. 58: 2185-99. PMID 8649205 DOI: 10.1016/0024-3205(96)00093-8  0.206
2012 Babineau BA, Yang M, Crawley JN. Mainstreaming mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 300-1. PMID 22157866 DOI: 10.1038/npp.2011.168  0.205
2011 Wöhr M, Roullet FI, Crawley JN. Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior. 10: 35-43. PMID 20345893 DOI: 10.1111/J.1601-183X.2010.00582.X  0.205
1994 Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides. 15: 731-55. PMID 7937354 DOI: 10.1016/0196-9781(94)90104-X  0.205
1992 Crawley J. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway The Journal of Neuroscience. 12: 3380-3391. DOI: 10.1523/JNEUROSCI.12-09-03380.1992  0.204
2015 Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology. PMID 26525567 DOI: 10.1007/S00213-015-4115-7  0.204
2023 Crawley JN. Twenty years of discoveries emerging from mouse models of autism. Neuroscience and Biobehavioral Reviews. 146: 105053. PMID 36682425 DOI: 10.1016/j.neubiorev.2023.105053  0.204
1987 Blumstein LK, Crawley JN, Davis LG, Baldino F. Neuropeptide modulation of apomorphine-induced stereotyped behavior. Brain Research. 404: 293-300. PMID 3567572 DOI: 10.1016/0006-8993(87)91381-3  0.203
2001 Wrenn CC, Crawley JN. Pharmacological evidence supporting a role for galanin in cognition and affect. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 283-99. PMID 11263757  0.202
1988 Crawley JN. Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens Brain Research. 473: 398-400. PMID 3233498 DOI: 10.1016/0006-8993(88)90874-8  0.202
2007 Yang M, Scattoni ML, Zhodzishsky V, Chen T, Caldwell H, Young WS, McFarlane HG, Crawley JN. Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. Frontiers in Behavioral Neuroscience. 1: 1. PMID 18958184 DOI: 10.3389/Neuro.08.001.2007  0.202
2011 Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.26. PMID 21732314 DOI: 10.1002/0471142301.ns0826s56  0.201
2003 Kinney JW, Starosta G, Crawley JN. Central galanin administration blocks consolidation of spatial learning. Neurobiology of Learning and Memory. 80: 42-54. PMID 12737933 DOI: 10.1016/S1074-7427(03)00023-6  0.201
1986 Crawley JN, Stivers JA, Martin JV, Mendelson WB. Cholinergic induction of seizures in the rat prefrontal cortex. Life Sciences. 38: 2347-54. PMID 3724361 DOI: 10.1016/0024-3205(86)90642-9  0.201
2007 Yang M, Zhodzishsky V, Crawley JN. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 25: 515-21. PMID 17980995 DOI: 10.1016/j.ijdevneu.2007.09.008  0.201
2016 Pearson BL, Crawley JN, Eilam D, Pentkowski NS, Summers CH. Curiosity as an approach to ethoexperimental analysis: behavioral neuroscience as seen by students and colleagues of Bob Blanchard. Neuroscience and Biobehavioral Reviews. PMID 27018381 DOI: 10.1016/J.Neubiorev.2016.03.012  0.199
2009 Kinney JW, Sanchez-Alavez M, Barr AM, Criado JR, Crawley JN, Behrens MM, Henriksen SJ, Bartfai T. Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylation. Neurobiology of Learning and Memory. 92: 429-38. PMID 19531380 DOI: 10.1016/J.Nlm.2009.06.005  0.199
1999 Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K, Proia RL. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. The Journal of Clinical Investigation. 103: 497-505. PMID 10021458 DOI: 10.1172/Jci5542  0.198
1993 Crawley JN. Functional interactions of galanin and acetylcholine: Relevance to memory and Alzheimer's disease Behavioural Brain Research. 57: 133-141. PMID 7509609 DOI: 10.1016/0166-4328(93)90129-E  0.198
1985 Crawley JN, Olschowka JA, Diz DI, Jacobowitz DM. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat Peptides. 6: 891-901. PMID 2417203 DOI: 10.1016/0196-9781(85)90320-1  0.196
2004 Yoshitake T, Wang FH, Kuteeva E, Holmberg K, Yamaguchi M, Crawley JN, Steiner R, Bartfai T, Ogren SO, Hökfelt T, Kehr J. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test. Proceedings of the National Academy of Sciences of the United States of America. 101: 354-9. PMID 14701907 DOI: 10.1073/pnas.0307042101  0.196
2018 Gulinello M, Mitchell HA, Chang Q, Timothy O'Brien W, Zhou Z, Abel T, Wang L, Corbin JG, Veeraragavan S, Samaco RC, Andrews NA, Fagiolini M, Cole TB, Burbacher TM, Crawley JN. Rigor and Reproducibility in Rodent Behavioral Research. Neurobiology of Learning and Memory. PMID 29307548 DOI: 10.1016/J.Nlm.2018.01.001  0.193
2011 Scattoni ML, Ricceri L, Crawley JN. Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters. Genes, Brain, and Behavior. 10: 44-56. PMID 20618443 DOI: 10.1111/j.1601-183X.2010.00623.x  0.193
1995 Mathis C, Neumann PE, Gershenfeld H, Paul SM, Crawley JN. Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behavior Genetics. 25: 557-68. PMID 8540894 DOI: 10.1007/Bf02327579  0.192
2002 Ouyang YB, Crawley JT, Aston CE, Moore KL. Reduced body weight and increased postimplantation fetal death in tyrosylprotein sulfotransferase-1-deficient mice. The Journal of Biological Chemistry. 277: 23781-7. PMID 11964405 DOI: 10.1074/jbc.M202420200  0.192
1989 Crawley JN. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion Synapse. 3: 346-355. PMID 2740993 DOI: 10.1002/SYN.890030408  0.19
1985 Crawley JN. Clarification of the behavioral functions of peripheral and central cholecystokinin: Two separate peptide pools Peptides. 6: 129-136. PMID 3001671 DOI: 10.1016/0196-9781(85)90145-7  0.189
1981 Crawley JN. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines Pharmacology, Biochemistry and Behavior. 15: 695-699. PMID 6118883 DOI: 10.1016/0091-3057(81)90007-1  0.188
2017 Stoppel LJ, Kazdoba TM, Schaffler MD, Preza AR, Heynen A, Crawley JN, Bear MF. R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28984295 DOI: 10.1038/npp.2017.236  0.187
1996 McDonald MP, Crawley JN. Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed-nonmatching-to-position task. Behavioral Neuroscience. 110: 1025-32. PMID 8919005  0.187
1997 McDonald MP, Crawley JN. Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease. Journal of Psychiatry & Neuroscience : Jpn. 22: 303-17. PMID 9401311  0.185
2002 Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, Esmon CT. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. The Journal of Biological Chemistry. 277: 43335-43. PMID 12218060 DOI: 10.1074/jbc.M207538200  0.184
2003 Grass S, Jacoby AS, Iismaa TP, Crawley JN, Xu XJ, Wiesenfeld-Hallin Z. Flexor reflex excitability in mice lacking galanin receptor galanin-R1. Neuroscience Letters. 345: 153-6. PMID 12842279 DOI: 10.1016/S0304-3940(03)00516-0  0.183
1988 Mastropaolo J, Crawley JN. Behavioral evidence for increased acetylcholine receptor sensitivity after nucleus basalis magnocellularis lesions in the rat European Journal of Pharmacology. 153: 301-304. PMID 3181290 DOI: 10.1016/0014-2999(88)90619-X  0.183
2019 Crawley JN, Fagiolini M, Harrison FE, Samaco R, Wozniak DF, Robinson MB. Behavioral Analyses of Animal Models of Intellectual and Developmental Disabilities. Neurobiology of Learning and Memory. 107087. PMID 31499164 DOI: 10.1016/J.Nlm.2019.107087  0.182
2015 Silverman JL, Gastrell PT, Karras MN, Solomon M, Crawley JN. Cognitive abilities on transitive inference using a novel touchscreen technology for mice. Cerebral Cortex (New York, N.Y. : 1991). 25: 1133-42. PMID 24293564 DOI: 10.1093/Cercor/Bht293  0.18
1986 Crawley JN, Glowa JR, Majewska MD, Paul SM. Anxiolytic activity of an endogenous adrenal steroid Brain Research. 398: 382-385. PMID 2879610 DOI: 10.1016/0006-8993(86)91500-3  0.179
1988 Crawley JN. Modulation of mesolimbic dopaminergic behaviors by cholecystokinin Annals of the New York Academy of Sciences. 537: 380-396. PMID 3059933 DOI: 10.1111/j.1749-6632.1988.tb42121.x  0.177
2015 Yang M, Mahrt EJ, Lewis F, Foley G, Portmann T, Dolmetsch RE, Portfors CV, Crawley JN. 16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions. Autism Research : Official Journal of the International Society For Autism Research. PMID 25663600 DOI: 10.1002/Aur.1465  0.176
2019 Le Duc D, Giulivi C, Hiatt SM, Napoli E, Panoutsopoulos A, Harlan De Crescenzo A, Kotzaeridou U, Syrbe S, Anagnostou E, Azage M, Bend R, Begtrup A, Brown NJ, Büttner B, Cho MT, ... ... Crawley JN, et al. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size. Brain : a Journal of Neurology. PMID 31327001 DOI: 10.1093/Brain/Awz198  0.176
2018 Matt L, Kirk LM, Chenaux G, Speca DJ, Puhger KR, Pride MC, Qneibi M, Haham T, Plambeck KE, Stern-Bach Y, Silverman JL, Crawley JN, Hell JW, Díaz E. SynDIG4/Prrt1 Is Required for Excitatory Synapse Development and Plasticity Underlying Cognitive Function. Cell Reports. 22: 2246-2253. PMID 29490264 DOI: 10.1016/J.Celrep.2018.02.026  0.175
1985 Crawley JN. Neurochemical investigation of the afferent pathway from the vagus nerve to the nucleus tractus solitarius in mediating the "satiety syndrome" induced by systemic cholecystokinin Peptides. 6: 133-137. PMID 4047976 DOI: 10.1016/0196-9781(85)90022-1  0.175
2008 Ryan BC, Young NB, Moy SS, Crawley JN. Olfactory cues are sufficient to elicit social approach behaviors but not social transmission of food preference in C57BL/6J mice. Behavioural Brain Research. 193: 235-42. PMID 18586054 DOI: 10.1016/j.bbr.2008.06.002  0.175
2019 Lauterborn JC, Schultz MN, Le AA, Amani M, Friedman AE, Leach PT, Gall CM, Lynch GS, Crawley JN. Spaced training improves learning in Ts65Dn and Ube3a mouse models of intellectual disabilities. Translational Psychiatry. 9: 166. PMID 31182707 DOI: 10.1038/S41398-019-0495-5  0.174
1986 Smith CB, Crawley JN. Anxiolytic action of CGS 9896 on mouse exploratory behavior. European Journal of Pharmacology. 132: 259-62. PMID 2880734 DOI: 10.1016/0014-2999(86)90613-8  0.174
1996 Crawley JN. Unusual behavioral phenotypes of inbred mouse strains. Trends in Neurosciences. 19: 181-2; discussion 18. PMID 8723201 DOI: 10.1016/S0166-2236(96)20021-9  0.174
1985 Crawley JN. A monoamine oxidase inhibitor reverses the 'separation syndrome' in a new hamster separation model of depression European Journal of Pharmacology. 112: 129-133. PMID 4040468 DOI: 10.1016/0014-2999(85)90250-X  0.172
2012 Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, Steinberg J, Crawley JN, Regehr WG, Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature. 488: 647-51. PMID 22763451 DOI: 10.1038/Nature11310  0.172
2014 Salles-Crawley II, Monkman JH, Ahnström J, Lane DA, Crawley JT. Vessel wall BAMBI contributes to hemostasis and thrombus stability. Blood. 123: 2873-81. PMID 24627527 DOI: 10.1182/blood-2013-10-534024  0.172
1989 Mefford IN, Lawrenz AL, Hsiao JK, Crawley JN. Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase. Psychopharmacology. 98: 240-4. PMID 2502794 DOI: 10.1007/BF00444698  0.169
1989 Merali Z, Merchant CA, Crawley JN, Coy DH, Heinz-Erian P, Jensen RT, Moody TW. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists. Synapse (New York, N.Y.). 2: 282-7. PMID 2463692 DOI: 10.1002/Syn.890020317  0.169
1998 Sills TL, Onalaja AO, Crawley JN. Mesolimbic dopaminergic mechanisms underlying individual differences in sugar consumption and amphetamine hyperlocomotion in Wistar rats. The European Journal of Neuroscience. 10: 1895-902. PMID 9751159  0.169
1998 McDonald MP, Willard LB, Wenk GL, Crawley JN. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5078-85. PMID 9634573 DOI: 10.1523/Jneurosci.18-13-05078.1998  0.168
1985 Crawley JN, Hommer DW, Skirboll LR. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Brain Research. 335: 337-41. PMID 4005562 DOI: 10.1016/0006-8993(85)90489-5  0.167
1994 Crawley JN. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens Annals of the New York Academy of Sciences. 713: 138-142. PMID 8185154 DOI: 10.1111/j.1749-6632.1994.tb44060.x  0.166
1984 Pohl R, Rainey JM, Gershon S, Enna SJ, Skolnick P, Ninan P, Insel T, Crawley J, Paul S, Eison MS, Goldberg HL, Gittelman R, Klein DF, Freedman RR, Ianni P, et al. Contents, Vol. 17, Supplement 1, 1984 Psychopathology. 17: 1-3. DOI: 10.1159/000284070  0.166
1989 Crawley JN, Wenk GL. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends in Neurosciences. 12: 278-82. PMID 2475942 DOI: 10.1016/0166-2236(89)90003-9  0.164
2014 Silverman JL, Crawley JN. The promising trajectory of autism therapeutics discovery. Drug Discovery Today. 19: 838-44. PMID 24362109 DOI: 10.1016/j.drudis.2013.12.007  0.162
2008 Scattoni ML, Gandhy SU, Ricceri L, Crawley JN. Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism. Plos One. 3: e3067. PMID 18728777 DOI: 10.1371/journal.pone.0003067  0.162
2010 Llaneza DC, DeLuke SV, Batista M, Crawley JN, Christodulu KV, Frye CA. Communication, interventions, and scientific advances in autism: a commentary. Physiology & Behavior. 100: 268-76. PMID 20093134 DOI: 10.1016/J.Physbeh.2010.01.003  0.161
1984 Crawley JN. Evaluation of a proposed hamster separation model of depression Psychiatry Research. 11: 35-47. PMID 6584930 DOI: 10.1016/0165-1781(84)90106-9  0.159
1997 McDonald MP, Wenk GL, Crawley JN. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin. Behavioral Neuroscience. 111: 552-63. PMID 9189270 DOI: 10.1037/0735-7044.111.3.552  0.157
2002 Gomeza J, Yamada M, Duttaroy A, Zhang W, Makita R, Miyakawa T, Crawley J, Zhang L, Shannon H, Bymaster FP, Felder CC, Deng C, Wess J. Muscarinic acetylcholine receptor knockout mice: Phenotypical analysis and clinical implications Pharmacochemistry Library. 32: 97-113. DOI: 10.1016/S0165-7208(02)80012-5  0.157
1988 Stivers JA, Crawley JN. Substance P antagonists block carbachol-induced "boxing" behavior at a site of coexistence in the rat prefrontal cortex Peptides. 9: 117-121. PMID 2485249 DOI: 10.1016/0196-9781(88)90235-5  0.155
1984 Crawley JN, Blumstein LK, Baldino F. Anxiolytic-like properties of fominoben. European Journal of Pharmacology. 97: 277-81. PMID 6142823 DOI: 10.1016/0014-2999(84)90460-6  0.153
2011 Roullet FI, Wöhr M, Crawley JN. Female urine-induced male mice ultrasonic vocalizations, but not scent-marking, is modulated by social experience. Behavioural Brain Research. 216: 19-28. PMID 20540967 DOI: 10.1016/J.Bbr.2010.06.004  0.153
1995 Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nature Genetics. 11: 170-6. PMID 7550345 DOI: 10.1038/Ng1095-170  0.151
2018 Ciernia AV, Yasui DH, Pride MC, Durbin-Johnson B, Noronha A, Chang A, Knotts T, Rutkowsky J, Ramsey JJ, Crawley JN, LaSalle JM. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome. Human Molecular Genetics. PMID 30137367 DOI: 10.1093/hmg/ddy301  0.15
2006 Tsai YS, Pendse A, Moy SS, Mohri I, Perez A, Crawley JN, Suzuki K, Maeda N. A de novo deafwaddler mutation of Pmca2 arising in ES cells and hitchhiking with a targeted modification of the Pparg gene. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 17: 716-22. PMID 16845470 DOI: 10.1007/S00335-005-0191-Z  0.149
2010 Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nature Reviews. Neuroscience. 11: 490-502. PMID 20559336 DOI: 10.1038/Nrn2851  0.149
1998 Norflus F, Tifft CJ, McDonald MP, Goldstein G, Crawley JN, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. The Journal of Clinical Investigation. 101: 1881-8. PMID 9576752 DOI: 10.1172/Jci2127  0.149
1996 Sills TL, Crawley JN. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens. European Journal of Pharmacology. 303: 177-81. PMID 8813564 DOI: 10.1016/0014-2999(96)00161-6  0.149
1984 Squires RF, Saederup E, Crawley JN, Skolnick P, Paul SM. Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sciences. 35: 1439-44. PMID 6090836 DOI: 10.1016/0024-3205(84)90159-0  0.148
2012 Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences of the United States of America. 109: 5469-74. PMID 22431635 DOI: 10.1073/Pnas.1112345109  0.147
1990 Austin MC, Cottingham SL, Paul SM, Crawley JN. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse (New York, N.Y.). 6: 351-7. PMID 1705056 DOI: 10.1002/Syn.890060407  0.145
2009 Yang M, Crawley JN. Simple behavioral assessment of mouse olfaction. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.24. PMID 19575474 DOI: 10.1002/0471142301.ns0824s48  0.143
1997 Gershenfeld HK, Neumann PE, Mathis C, Crawley JN, Li X, Paul SM. Mapping quantitative trait loci for open-field behavior in mice. Behavior Genetics. 27: 201-10. PMID 9210791  0.142
2002 Gold LH, Crawley JN. Introduction: transgenics and knockouts with mutations in genes for neuropeptides and their receptors. Neuropeptides. 36: 61. PMID 12398063 DOI: 10.1054/npep.2002.0908  0.142
1989 Zohar J, Murphy DL, Crawley JN. Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 775-9. PMID 2675195 DOI: 10.1016/0278-5846(89)90064-X  0.141
2002 Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, Mufson EJ. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. Journal of Neurochemistry. 83: 442-51. PMID 12423254 DOI: 10.1046/j.1471-4159.2002.01148.x  0.141
2018 Deurloo MHS, Turlova E, Chen WL, Lin YW, Tam E, Tassew NG, Wu M, Huang YC, Crawley JN, Monnier PP, Groffen AJA, Sun HS, Osborne LR, Feng ZP. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models. Molecular Neurobiology. PMID 30120731 DOI: 10.1007/S12035-018-1290-7  0.139
1998 Cheng CM, Joncas G, Reinhardt RR, Farrer R, Quarles R, Janssen J, McDonald MP, Crawley JN, Powell-Braxton L, Bondy CA. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5673-81. PMID 9671658  0.138
1982 Crawley JN, Patel J, Marangos PJ. Behavioral characterization of two long-lasting adenosine analogs: sedative properties and interaction with diazepam. Life Sciences. 29: 2623-30. PMID 7321779 DOI: 10.1016/0024-3205(81)90636-6  0.136
1987 Angel I, Stivers JA, Paul SM, Crawley JN. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding. Pharmacology, Biochemistry, and Behavior. 27: 291-7. PMID 3628443 DOI: 10.1016/0091-3057(87)90572-7  0.135
1988 Khosla S, Crawley JN. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin Life Sciences. 42: 153-159. PMID 3336275 DOI: 10.1016/0024-3205(88)90678-9  0.133
2011 Mogil JS, Sorge RE, LaCroix-Fralish ML, Smith SB, Fortin A, Sotocinal SG, Ritchie J, Austin JS, Schorscher-Petcu A, Melmed K, Czerminski J, Bittong RA, Mokris JB, Neubert JK, Campbell CM, ... ... Crawley JN, et al. Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nature Neuroscience. 14: 1569-73. PMID 22019732 DOI: 10.1038/Nn.2941  0.131
2016 Crawley JN, Heyer WD, LaSalle JM. Autism and Cancer Share Risk Genes, Pathways, and Drug Targets. Trends in Genetics : Tig. PMID 26830258 DOI: 10.1016/J.Tig.2016.01.001  0.13
1991 De Mesquita S, Beinfeld MC, Crawley JN. Microdialysis as an approach to quantitate the release of neuropeptides. Progress in Neuro-Psychopharmacology & Biological Psychiatry. S5-15. PMID 2097673 DOI: 10.1016/0278-5846(90)90083-S  0.129
1996 Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nature Genetics. 14: 348-52. PMID 8896570 DOI: 10.1038/Ng1196-348  0.125
1994 Evans RW, Crawley JB, Garratt RC, Grossmann JG, Neu M, Aitken A, Patel KJ, Meilak A, Wong C, Singh J. Characterization and structural analysis of a functional human serum transferrin variant and implications for receptor recognition. Biochemistry. 33: 12512-20. PMID 7918474 DOI: 10.1021/bi00207a019  0.123
1979 Crawley JN, Laverty R, Roth RH. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. European Journal of Pharmacology. 57: 247-50. PMID 573692 DOI: 10.1016/0014-2999(79)90372-8  0.122
2007 Hohmann CF, Crawley JN. Foreword Behavioural Brain Research. 176: 1-3. DOI: 10.1016/j.bbr.2006.10.010  0.12
1996 Hoffmann A, Okuda Y, Grinberg A, McDonald MP, Sandhoff K, Crawley JN, Westphal H, Proia RL. Proceedings of the Japanese Society of Animal Models For Human Diseases. 12: 52-52. DOI: 10.1538/expanim1992.12.52  0.12
1995 Crawley JN, Grinberg A, Johnson MD, Westphal H, Proia RL. Proceedings of the Japanese Society of Animal Models For Human Diseases. 11: 77-77. DOI: 10.1538/EXPANIM1992.11.77  0.12
2009 Chadman KK, Yang M, Crawley JN. Criteria for validating mouse models of psychiatric diseases. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 1-11. PMID 18484083 DOI: 10.1002/Ajmg.B.30777  0.119
1995 Corwin RL, Jörn A, Hardy M, Crawley JN. The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism. Journal of Neurochemistry. 65: 208-17. PMID 7790862 DOI: 10.1046/J.1471-4159.1995.65010208.X  0.118
1984 Yachnis AT, Crawley JN, Jensen RT, McGrane MM, Moody TW. The antagonism of bombesin in the CNS by substance P analogues. Life Sciences. 35: 1963-9. PMID 6208451 DOI: 10.1016/0024-3205(84)90477-6  0.118
2012 Katz DM, Berger-Sweeney JE, Eubanks JH, Justice MJ, Neul JL, Pozzo-Miller L, Blue ME, Christian D, Crawley JN, Giustetto M, Guy J, Howell CJ, Kron M, Nelson SB, Samaco RC, et al. Preclinical research in Rett syndrome: setting the foundation for translational success. Disease Models & Mechanisms. 5: 733-45. PMID 23115203 DOI: 10.1242/Dmm.011007  0.116
1985 Hirsch MD, O'Donohue TL, Wilson R, Sawyer TK, Hruby VJ, Hadley ME, Cody WL, Knittel JJ, Crawley JN. Structural and conformational modifications of alpha-MSH/ACTH4-10 provide melanotropin analogues with highly potent behavioral activities. Peptides. 5: 1197-201. PMID 6099564 DOI: 10.1016/0196-9781(84)90187-6  0.113
2015 Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, DiCicco-Bloom E, Lai JK, Foster JA, Peñagarikano O, Geschwind DH, Pacey LK, Hampson DR, Laliberté CL, Mills AA, et al. Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Molecular Psychiatry. 20: 118-25. PMID 25199916 DOI: 10.1038/Mp.2014.98  0.111
2013 Yang M, Loureiro D, Kalikhman D, Crawley JN. Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena. Frontiers in Behavioral Neuroscience. 7: 159. PMID 24312027 DOI: 10.3389/fnbeh.2013.00159  0.11
1989 Crawley JN. Animal models of anxiety Current Opinion in Psychiatry. 2: 773-776. DOI: 10.1097/00001504-198912000-00012  0.108
1992 Snider RM, Pereira DA, Longo KP, Davidson RE, Vinick FJ, Laitinen K, Genc-Sehitoglu E, Crawley JN. UK-73,093: A non-peptide neurotensin receptor antagonist Bioorganic and Medicinal Chemistry Letters. 2: 1535-1540. DOI: 10.1016/S0960-894X(00)80423-0  0.107
2002 Luttun A, Lupu F, Storkebaum E, Hoylaerts MF, Moons L, Crawley J, Bono F, Poole AR, Tipping P, Herbert JM, Collen D, Carmeliet P. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 499-505. PMID 11884297 DOI: 10.1161/Hq0302.104529  0.105
2004 Wrenn CC, Dreiling JL, Stephenson D, Sullivan T, Crawley JN. P1-432 Galanin inhibits trace fear conditioning via the GAL-R1 subtype of galanin receptor Neurobiology of Aging. 25: S222. DOI: 10.1016/S0197-4580(04)80744-9  0.104
2006 Mollica LR, Crawley JT, Liu K, Rance JB, Cockerill PN, Follows GA, Landry JR, Wells DJ, Lane DA. Role of a 5'-enhancer in the transcriptional regulation of the human endothelial cell protein C receptor gene. Blood. 108: 1251-9. PMID 16627757 DOI: 10.1182/blood-2006-02-001461  0.103
2015 Andreou AP, Efthymiou M, Yu Y, Watts HR, Noormohamed FH, Ma D, Lane DA, Crawley JT. Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke. Plos One. 10: e0122410. PMID 25830552 DOI: 10.1371/journal.pone.0122410  0.101
2010 de Groot R, Lane DA, Crawley JT. The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity. Blood. 116: 3064-72. PMID 20647566 DOI: 10.1182/blood-2009-12-258780  0.101
2010 Andersson HM, Arantes MJ, Crawley JT, Luken BM, Tran S, Dahlbäck B, Lane DA, Rezende SM. Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood. 115: 4878-85. PMID 20308596 DOI: 10.1182/Blood-2009-11-256610  0.099
2001 Mobbs CV, Bray GA, Atkinson RL, Bartke A, Finch CE, Maratos-Flier E, Crawley JN, Nelson JF. Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 56: 34-44. PMID 12088210 DOI: 10.1093/Gerona/56.Suppl_1.34  0.097
2008 Camilleri RS, Cohen H, Mackie IJ, Scully M, Starke RD, Crawley JT, Lane DA, Machin SJ. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis : Jth. 6: 331-8. PMID 18031293 DOI: 10.1111/j.1538-7836.2007.02846.x  0.093
2011 Ahnström J, Andersson HM, Canis K, Norstrøm E, Yu Y, Dahlbäck B, Panico M, Morris HR, Crawley JT, Lane DA. Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue. Blood. 117: 6685-93. PMID 21508412 DOI: 10.1182/Blood-2010-11-317099  0.092
2005 Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin. 31: 882-7. PMID 16135561 DOI: 10.1093/Schbul/Sbi049  0.09
1983 CAIN M, WEBER RW, GUZMAN F, COOK JM, BARKER SA, RICE KC, CRAWLEY JN, PAUL SM, SKOLNICK P. ChemInform Abstract: β-CARBOLINES: SYNTHESIS AND NEUROCHEMICAL AND PHARMACOLOGICAL ACTIONS ON BRAIN BENZODIAZEPINE RECEPTORS Chemischer Informationsdienst. 14. DOI: 10.1002/Chin.198305238  0.09
2002 Crawley JT, Gu JM, Ferrell G, Esmon CT. Distribution of endothelial cell protein C/activated protein C receptor (EPCR) during mouse embryo development. Thrombosis and Haemostasis. 88: 259-66. PMID 12195698  0.089
2010 Bailey KR, Crawley JN. Galanin and Receptors Encyclopedia of Neuroscience. 491-498. DOI: 10.1016/B978-008045046-9.01441-8  0.087
2007 Crawley JT. Multiple roles of the endothelial cell protein C receptor. Journal of Thrombosis and Haemostasis : Jth. 5: 1813-6. PMID 17723118 DOI: 10.1111/j.1538-7836.2007.02685.x  0.086
1985 CRAWLEY JN, KISS JZ. Tracing the Sensory Pathway from the Gut to Brain Regions Mediating the Actions of Cholecystokinin on Feeding and Exploration Annals of the New York Academy of Sciences. 448: 586-588. DOI: 10.1111/j.1749-6632.1985.tb29957.x  0.086
2012 Ahnström J, Andersson HM, Hockey V, Meng Y, McKinnon TA, Hamuro T, Crawley JT, Lane DA. Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S. Blood. 120: 5059-62. PMID 23074276 DOI: 10.1182/blood-2012-05-432005  0.085
2013 Crawley JT, Scully MA. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2013: 292-9. PMID 24319194 DOI: 10.1182/asheducation-2013.1.292  0.084
2006 Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, Tessarollo L, Dupree JL, Bhat MA. Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proceedings of the National Academy of Sciences of the United States of America. 103: 5137-42. PMID 16551741 DOI: 10.1073/Pnas.0601082103  0.082
2009 de Groot R, Bardhan A, Ramroop N, Lane DA, Crawley JT. Essential role of the disintegrin-like domain in ADAMTS13 function. Blood. 113: 5609-16. PMID 19234142 DOI: 10.1182/blood-2008-11-187914  0.081
2008 Crawley JT, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 233-42. PMID 17951326 DOI: 10.1161/ATVBAHA.107.141606  0.081
2012 Crawley J, Jackson WA, Anderson T, Song L, Morse A. Evaluating RO performance with biological pretreatment of graywater Journal of Water Reuse and Desalination. 2: 109-120. DOI: 10.2166/Wrd.2012.075  0.081
1982 Cain M, Weber RW, Guzman F, Cook JM, Barker SA, Rice KC, Crawley JN, Paul SM, Skolnick P. Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. Journal of Medicinal Chemistry. 25: 1081-91. PMID 6127411 DOI: 10.1021/Jm00351A015  0.079
1999 Crawley JN. Chapter 4.6 Evaluating anxiety in rodents Techniques in the Behavioral and Neural Sciences. 13: 667-673. DOI: 10.1016/S0921-0709(99)80052-2  0.079
2014 Kiguli S, Akech SO, Mtove G, Opoka RO, Engoru C, Olupot-Olupot P, Nyeko R, Evans J, Crawley J, Prevatt N, Reyburn H, Levin M, George EC, South A, Babiker AG, et al. Authors' reply to Southall. Bmj (Clinical Research Ed.). 348: g1619. PMID 24554466 DOI: 10.1136/Bmj.G1619  0.077
2007 Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: Recommandations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference | Cognition sociale et schizophrénie: Recommandations de la conférence sur les nouvelles approches MATRICS Information Psychiatrique. 83: 99-106. DOI: 10.1684/ipe.2007.0093  0.077
2010 Pos W, Crawley JT, Fijnheer R, Voorberg J, Lane DA, Luken BM. An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF. Blood. 115: 1640-9. PMID 20032502 DOI: 10.1182/blood-2009-06-229203  0.075
1999 Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacological Reviews. 51: 745-81. PMID 10581329  0.075
2006 Zanardelli S, Crawley JT, Chion CK, Lam JK, Preston RJ, Lane DA. ADAMTS13 substrate recognition of von Willebrand factor A2 domain. The Journal of Biological Chemistry. 281: 1555-63. PMID 16221672 DOI: 10.1074/jbc.M508316200  0.075
1990 Crawley JN. Coexistence of neuropeptides and 'Classical' Neurotransmitters. Functional interactions between galanin and acetylcholine Annals of the New York Academy of Sciences. 579: 233-245. PMID 1692455 DOI: 10.1111/j.1749-6632.1990.tb48365.x  0.075
2014 South K, Luken BM, Crawley JT, Phillips R, Thomas M, Collins RF, Deforche L, Vanhoorelbeke K, Lane DA. Conformational activation of ADAMTS13. Proceedings of the National Academy of Sciences of the United States of America. 111: 18578-83. PMID 25512499 DOI: 10.1073/pnas.1411979112  0.075
1983 Rojas-Ramirez JA, Crawley JN, Mendelson WB. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin. Neuropeptides. 3: 129-38. PMID 7162563 DOI: 10.1016/0143-4179(82)90008-7  0.075
2015 de Groot R, Lane DA, Crawley JT. The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis. Blood. 125: 1968-75. PMID 25564400 DOI: 10.1182/blood-2014-08-594556  0.074
2011 Xiang Y, de Groot R, Crawley JT, Lane DA. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13). Proceedings of the National Academy of Sciences of the United States of America. 108: 11602-7. PMID 21705658 DOI: 10.1073/pnas.1018559108  0.073
2014 Crawley JT, Hasan K, Hannay HJ, Dennis M, Jockell C, Fletcher JM. Structure, integrity, and function of the hypoplastic corpus callosum in spina bifida myelomeningocele. Brain Connectivity. 4: 608-18. PMID 25014561 DOI: 10.1089/Brain.2014.0237  0.073
2009 Gardner MD, Chion CK, de Groot R, Shah A, Crawley JT, Lane DA. A functional calcium-binding site in the metalloprotease domain of ADAMTS13. Blood. 113: 1149-57. PMID 19047683 DOI: 10.1182/blood-2008-03-144683  0.073
2007 Crawley JN. Medicine. Testing hypotheses about autism. Science (New York, N.Y.). 318: 56-7. PMID 17916718 DOI: 10.1126/science.1149801  0.073
2005 O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood. 106: 1988-91. PMID 15886321 DOI: 10.1182/blood-2005-02-0792  0.072
1995 Davis TM, Supanaranond W, Pukrittayakamee S, Crawley JC, Villaiwanna N, White NJ. The effect of plasma free fatty acids and long-chain triglycerides on glucose metabolism in uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89: 511-5. PMID 8560527 DOI: 10.1016/0035-9203(95)90090-X  0.072
2014 RegliÅ„ska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JT, Lane DA, Ahnström J. TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain. Blood. 123: 3979-87. PMID 24740810 DOI: 10.1182/Blood-2014-01-551812  0.072
2002 Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biology. 3: RESEARCH0075. PMID 12537564  0.071
2008 Crawley JT, Efthymiou M. Cytoprotective effect of activated protein C: specificity of PAR-1 signaling. Journal of Thrombosis and Haemostasis : Jth. 6: 951-3. PMID 18363817 DOI: 10.1111/j.1538-7836.2008.02951.x  0.07
2011 Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 118: 3212-21. PMID 21715306 DOI: 10.1182/blood-2011-02-306597  0.069
2011 White ML, Crawley J, Rennie EA, Lewandowski LA. Examining the effectiveness of 2 solutions used to flush capped pediatric peripheral intravenous catheters. Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society. 34: 260-70. PMID 21734522 DOI: 10.1097/NAN.0b013e31821da29a  0.069
2008 Crawley JT, Lane DA, Woodward M, Rumley A, Lowe GD. Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. Journal of Thrombosis and Haemostasis : Jth. 6: 583-8. PMID 18194418 DOI: 10.1111/j.1538-7836.2008.02902.x  0.068
1997 Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circulation Research. 81: 829-39. PMID 9351457 DOI: 10.1161/01.Res.81.5.829  0.067
2010 Smith TJ, Yamamoto K, Kurata M, Yukimori A, Suzuki S, Umeda S, Sugawara E, Kojima Y, Sawabe M, Nakagawa Y, Suzuki K, Crawley JT, Kitagawa M. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. Experimental and Molecular Pathology. 89: 284-90. PMID 20800061 DOI: 10.1016/j.yexmp.2010.08.003  0.067
1991 Crawley JN. Heuristic Animal Models of Human Psychoses Contemporary Psychology: a Journal of Reviews. 36: 613-614. DOI: 10.1037/029945  0.066
2013 Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, Opoka RO, Engoru C, Nyeko R, Mtove G, Reyburn H, Brent B, Nteziyaremye J, Mpoya A, Prevatt N, ... ... Crawley J, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. Bmc Medicine. 11: 68. PMID 23496872 DOI: 10.1186/1741-7015-11-68  0.066
2009 Konstantinou K, Yamamoto K, Ishibashi F, Mizoguchi Y, Kurata M, Nakagawa Y, Suzuki K, Sawabe M, Ohta M, Miyakoshi S, Crawley JT, Kitagawa M. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. British Journal of Haematology. 144: 696-704. PMID 19120365 DOI: 10.1111/j.1365-2141.2008.07534.x  0.065
2005 Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood. 105: 1085-93. PMID 15388580 DOI: 10.1182/blood-2004-03-1101  0.065
1995 Abbott LC, Conforti ML, Isaacs KR, Crawley JN, Sterchi D. A simplified technique for histologic analysis of central nervous system tissues using glycol-methacrylate plastic coupled with pre-embedding immunocytochemistry. Journal of Neuroscience Methods. 54: 23-9. PMID 7529349 DOI: 10.1016/0165-0270(94)90156-2  0.065
2002 Crawley JT, Goulding DA, Ferreira V, Severs NJ, Lupu F. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 218-24. PMID 11834519 DOI: 10.1161/Hq0102.101842  0.063
2015 Vallerand AH, Crawley J, Pieper B, Templin TN. The Perceived Control over Pain Construct and Functional Status. Pain Medicine (Malden, Mass.). PMID 26350223 DOI: 10.1111/pme.12924  0.063
1987 Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM. Response: seizures in drug-treated animals. Science (New York, N.Y.). 235: 1127b-8b. PMID 17818967 DOI: 10.1126/Science.235.4793.1127B  0.062
2005 Kim J, Keininger DL, Becker S, Crawley JA. Simultaneous development of the Pediatric GERD Caregiver Impact Questionnaire (PGCIQ) in American English and American Spanish. Health and Quality of Life Outcomes. 3: 5. PMID 15651991 DOI: 10.1186/1477-7525-3-5  0.06
2010 Kedward AL, Crawley JM, Armstrong KD, Marley J, Cowan G, Lamey PJ. The role of patch testing in oral disease. Dermatitis : Contact, Atopic, Occupational, Drug. 21: 294-6. PMID 20920420 DOI: 10.2310/6620.2010.10029  0.059
2012 Scott JA, Wonodi C, Moïsi JC, Deloria-Knoll M, DeLuca AN, Karron RA, Bhat N, Murdoch DR, Crawley J, Levine OS, O'Brien KL, Feikin DR. The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S109-16. PMID 22403224 DOI: 10.1093/Cid/Cir1065  0.057
2015 George EC, Walker AS, Kiguli S, Olupot-Olupot P, Opoka RO, Engoru C, Akech SO, Nyeko R, Mtove G, Reyburn H, Berkley JA, Mpoya A, Levin M, Crawley J, Gibb DM, et al. Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score. Bmc Medicine. 13: 174. PMID 26228245 DOI: 10.1186/S12916-015-0407-3  0.057
2013 Crawley J, Kane D, Atkinson-Plato L, Hamilton M, Dobson K, Watson J. Needs of the hidden homeless - no longer hidden: a pilot study. Public Health. 127: 674-80. PMID 23806186 DOI: 10.1016/J.Puhe.2013.04.006  0.056
2004 Crawley J, Nahlen B. Prevention and treatment of malaria in young African children. Seminars in Pediatric Infectious Diseases. 15: 169-80. PMID 15480963 DOI: 10.1053/j.spid.2004.05.009  0.056
2000 Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, Lupu C. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1362-73. PMID 10807755  0.055
2007 Lam JK, Chion CK, Zanardelli S, Lane DA, Crawley JT. Further characterization of ADAMTS-13 inactivation by thrombin. Journal of Thrombosis and Haemostasis : Jth. 5: 1010-8. PMID 17355572 DOI: 10.1111/j.1538-7836.2007.02514.x  0.055
2014 Coyne KS, Currie BM, Holmes WC, Crawley JA. Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience. The Patient. PMID 25231829 DOI: 10.1007/s40271-014-0087-7  0.055
1996 Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Qjm : Monthly Journal of the Association of Physicians. 89: 591-7. PMID 8935480 DOI: 10.1093/Qjmed/89.8.591  0.053
2015 Paquin K, Ali S, Carr K, Crawley J, McGowan C, Horton S. Effectiveness of commercial video gaming on fine motor control in chronic stroke within community-level rehabilitation. Disability and Rehabilitation. 1-8. PMID 25586794 DOI: 10.3109/09638288.2014.1002574  0.053
2007 Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. Journal of Thrombosis and Haemostasis : Jth. 5: 95-101. PMID 17635715 DOI: 10.1111/j.1538-7836.2007.02500.x  0.053
2013 Vallerand AH, Pieper B, Crawley J, Nordstrom C, DiNardo E. The prevalence of pain and its association with psychosocial factors for indigent adults enrolled in a primary care clinic. The Clinical Journal of Pain. 29: 917-23. PMID 23370079 DOI: 10.1097/Ajp.0B013E31827C7B30  0.052
2011 Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, et al. Mortality after fluid bolus in African children with severe infection. The New England Journal of Medicine. 364: 2483-95. PMID 21615299 DOI: 10.1056/Nejmoa1101549  0.051
1995 Crawley JN. Biological actions of galanin. Regulatory Peptides. 59: 1-16. PMID 12506409 DOI: 10.1016/0167-0115(95)00083-N  0.05
1996 Bethell DB, Phuong PT, Phuong CX, Nosten F, Waller D, Davis TM, Day NP, Crawley J, Brewster D, Pukrittayakamee S, White NJ. Electrocardiographic monitoring in severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90: 266-9. PMID 8758072 DOI: 10.1016/S0035-9203(96)90241-2  0.05
1981 Swann AC, Crawley JN, Grant SJ, Maas JW. Noradrenergic stimulation in vivo increases (Na+, K+)-adenosine triphosphatase activity. Life Sciences. 28: 251-6. PMID 6261058 DOI: 10.1016/0024-3205(81)90730-X  0.05
1998 Grossmann JG, Crawley JB, Strange RW, Patel KJ, Murphy LM, Neu M, Evans RW, Hasnain SS. The nature of ligand-induced conformational change in transferrin in solution. An investigation using X-ray scattering, XAFS and site-directed mutants. Journal of Molecular Biology. 279: 461-72. PMID 9642050 DOI: 10.1006/Jmbi.1998.1787  0.049
2012 Crawley J, Ditzel L, Walton S. Using children's picture books for reflective learning in nurse education. Contemporary Nurse. 42: 45-52. PMID 23050571 DOI: 10.5172/conu.2012.42.1.45  0.049
1996 Crawley JB, Willcocks J, Foxwell BM. Interleukin-7 induces T cell proliferation in the absence of Erk/MAP kinase activity. European Journal of Immunology. 26: 2717-23. PMID 8921960 DOI: 10.1002/eji.1830261125  0.049
1997 Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. The Journal of Biological Chemistry. 272: 15023-7. PMID 9169478  0.044
2010 Luken BM, Winn LY, Emsley J, Lane DA, Crawley JT. The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function. Blood. 115: 4910-3. PMID 20354169 DOI: 10.1182/blood-2009-12-257949  0.044
2010 Suzdak PD, Glowa JR, Crawley JN, Skolnick P, Paul SM. Response: is ethanol antagonist rol5-4513 selective for ethanol? Science (New York, N.Y.). 239: 649-50. PMID 17759061 DOI: 10.1126/Science.239.4840.649  0.043
1985 Crawley JN. Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides? Annals of the New York Academy of Sciences. 1-8. PMID 3861115 DOI: 10.1111/j.1749-6632.1985.tb29900.x  0.043
2012 Salles II, Crawley JT. Blocking VWF platelet binding to treat TTP. Blood. 120: 3390-2. PMID 23100301 DOI: 10.1182/blood-2012-08-448530  0.043
2012 Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, Rosendaal FR. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood. 119: 1555-60. PMID 22110247 DOI: 10.1182/blood-2011-09-380618  0.042
2004 Crawley J. Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. The American Journal of Tropical Medicine and Hygiene. 71: 25-34. PMID 15331816  0.041
1984 Crawley JN. Preliminary report of a new rodent separation model of depression Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8: 447-457. DOI: 10.1016/S0278-5846(84)80033-0  0.04
2001 Smith C, Andreakos E, Crawley JB, Brennan FM, Feldmann M, Foxwell BM. NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. Journal of Immunology (Baltimore, Md. : 1950). 167: 5895-903. PMID 11698466  0.039
2004 Lali FV, Crawley J, McCulloch DA, Foxwell BM. A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation. Journal of Immunology (Baltimore, Md. : 1950). 172: 3527-34. PMID 15004153  0.039
2003 Revicki DA, Zodet MW, Joshua-Gotlib S, Levine D, Crawley JA. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health and Quality of Life Outcomes. 1: 73. PMID 14641914 DOI: 10.1186/1477-7525-1-73  0.038
1995 Zak O, Aisen P, Crawley JB, Joannou CL, Patel KJ, Rafiq M, Evans RW. Iron release from recombinant N-lobe and mutants of human transferrin. Biochemistry. 34: 14428-34. PMID 7578047 DOI: 10.1021/bi00044a020  0.038
2004 Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax. 59: 334-6. PMID 15047956  0.038
1999 Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 13: 1621-30. PMID 10594397 DOI: 10.1046/j.1365-2036.1999.00669.x  0.038
2013 Gwer SA, Idro RI, Fegan G, Chengo EM, Mpoya A, Kivaya E, Crawley J, Muchohi SN, Kihara MN, Ogutu BR, Kirkham FJ, Newton CR. Fosphenytoin for seizure prevention in childhood coma in Africa: a randomized clinical trial. Journal of Critical Care. 28: 1086-92. PMID 24135012 DOI: 10.1016/j.jcrc.2013.09.001  0.038
2012 Alemayehu B, Ke X, Youssef NN, Crawley JA, Levine DS. Esomeprazole formulary exclusion: impact on total health care services use and costs. Postgraduate Medicine. 124: 149-63. PMID 22691909 DOI: 10.3810/pgm.2012.05.2558  0.037
2001 Crawley J, Smith S, Muthinji P, Marsh K, Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Archives of Disease in Childhood. 84: 247-53. PMID 11207176 DOI: 10.1136/Adc.84.3.247  0.037
2006 Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, Hwang C, Sostek MB, Shaker R. Treatment of chronic posterior laryngitis with esomeprazole. The Laryngoscope. 116: 254-60. PMID 16467715 DOI: 10.1097/01.mlg.0000192173.00498.ba  0.037
2010 Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet. 375: 1468-81. PMID 20417858 DOI: 10.1016/S0140-6736(10)60447-3  0.035
2000 Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet. 355: 701-6. PMID 10703801 DOI: 10.1016/S0140-6736(99)07148-2  0.033
2002 Ogutu BR, Newton CR, Crawley J, Muchohi SN, Otieno GO, Edwards G, Marsh K, Kokwaro GO. Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. British Journal of Clinical Pharmacology. 53: 49-57. PMID 11849195 DOI: 10.1046/J.0306-5251.2001.01529.X  0.033
2015 Kiguli S, Maitland K, George EC, Olupot-Olupot P, Opoka RO, Engoru C, Akech SO, Nyeko R, Mtove G, Reyburn H, Levin M, Babiker AG, Gibb DM, Crawley J. Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. Bmc Medicine. 13: 21. PMID 25640706 DOI: 10.1186/S12916-014-0246-7  0.032
2001 Kleinman L, Leidy NK, Crawley J, Bonomi A, Schoenfeld P. A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire. Medical Care. 39: 181-9. PMID 11176555  0.031
1997 Newton CR, Crawley J, Sowumni A, Waruiru C, Mwangi I, English M, Murphy S, Winstanley PA, Marsh K, Kirkham FJ. Intracranial hypertension in Africans with cerebral malaria. Archives of Disease in Childhood. 76: 219-26. PMID 9135262  0.031
2009 Gunasekaran T, Tolia V, Colletti RB, Gold BD, Traxler B, Illueca M, Crawley JA. Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study. Bmc Gastroenterology. 9: 84. PMID 19922626 DOI: 10.1186/1471-230X-9-84  0.03
2015 Mumby HS, Chapman SN, Crawley JA, Mar KU, Htut W, Thura Soe A, Aung HH, Lummaa V. Distinguishing between determinate and indeterminate growth in a long-lived mammal. Bmc Evolutionary Biology. 15: 214. PMID 26464339 DOI: 10.1186/s12862-015-0487-x  0.03
2015 Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR. Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis. Journal of Thrombosis and Haemostasis : Jth. 13: 1396-404. PMID 26073931 DOI: 10.1111/jth.13032  0.029
1996 English M, Waruiru C, Amukoye E, Murphy S, Crawley J, Mwangi I, Peshu N, Marsh K. Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. The American Journal of Tropical Medicine and Hygiene. 55: 521-4. PMID 8940984 DOI: 10.4269/AJTMH.1996.55.521  0.029
2007 Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J, Crawley J, Fegan G, Bauni E, Peshu N, Marsh K, Neville B, Newton C. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. Jama. 297: 2232-40. PMID 17519413 DOI: 10.1001/jama.297.20.2232  0.029
2011 Welle J, Fort J, Crawley J, Cryer B, Dickerhoof R, Turner MP, Miller KL. Modified Severity of Dyspepsia Assessment pain scale: a new tool for measuring upper abdominal pain in osteoarthritis patients taking NSAIDs. Patient Related Outcome Measures. 2: 135-43. PMID 22915974 DOI: 10.2147/PROM.S18077  0.027
1995 Cobb MM, Johnson D, Gallo J, Crawley JA, Cargo PH, Lefkowitz MP. Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. American Journal of Therapeutics. 2: 455-461. PMID 11850691  0.027
2005 Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Current Medical Research and Opinion. 21: 535-44. PMID 15899102 DOI: 10.1185/030079905X38240  0.027
1996 Crawley JB, Williams LM, Mander T, Brennan FM, Foxwell BM. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine. The Journal of Biological Chemistry. 271: 16357-62. PMID 8663063  0.027
1998 Crawley J, English M, Waruiru C, Mwangi I, Marsh K. Abnormal respiratory patterns in childhood cerebral malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92: 305-8. PMID 9861404 DOI: 10.1016/S0035-9203(98)91023-9  0.026
2002 Kleinman L, McIntosh E, Ryan M, Schmier J, Crawley J, Locke GR, De Lissovoy G. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Archives of Internal Medicine. 162: 1361-6. PMID 12076234  0.025
2005 Egan A, Crawley J, Schellenberg D. Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action. Tropical Medicine & International Health : Tm & Ih. 10: 815-7. PMID 16135186 DOI: 10.1111/j.1365-3156.2005.01474.x  0.025
2009 Gosselin A, Luo R, Lohoues H, Toy E, Lewis B, Crawley J, Duh MS. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 34-9. PMID 19895371 DOI: 10.1111/j.1524-4733.2008.00399.x  0.024
1997 Cohen SB, Crawley JB, Kahan MC, Feldmann M, Foxwell BM. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology. 92: 1-5. PMID 9370916  0.024
2011 Crawley J. I'll meet you half way. Nursing Standard (Royal College of Nursing (Great Britain) : 1987). 25: 64. PMID 21706982 DOI: 10.7748/ns2011.05.25.38.64.p5337  0.024
2012 Crawley J, Sismanidis C, Goodman T, Milligan P. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials. Lancet. 380: 1001-10. PMID 22850358 DOI: 10.1016/S0140-6736(12)60775-2  0.023
1996 Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, Newton C, Winstanley P, Peshu N, Marsh K. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90: 298-301. PMID 8758084 DOI: 10.1016/S0035-9203(96)90260-6  0.023
2010 Johnson D, Crawley JA, Hwang C, Brown K. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances. Alimentary Pharmacology & Therapeutics. 32: 182-90. PMID 20456306 DOI: 10.1111/j.1365-2036.2010.04339.x  0.023
2000 Dobbie M, Crawley J, Waruiru C, Marsh K, Surtees R. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? The American Journal of Tropical Medicine and Hygiene. 62: 284-90. PMID 10813486 DOI: 10.4269/AJTMH.2000.62.284  0.023
2001 Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I. Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Digestive Diseases and Sciences. 46: 571-80. PMID 11318535 DOI: 10.1023/A:1005655317121  0.022
2004 Crawley JA. Improving health-related quality of life in patients with gastroesophageal reflux disease. Director (Cincinnati, Ohio). 12: 89-93. PMID 15106370  0.022
2003 Shaw MJ, Crawley JA. Improving health-related quality of life in gastro-oesophageal reflux disease. Drugs. 63: 2307-16. PMID 14524732  0.02
2000 Braybrooke JP, Houlbrook S, Crawley JE, Propper DJ, O'Byrne KJ, Stratford IJ, Harris AL, Shuker DE, Talbot DC. Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen. Cancer Chemotherapy and Pharmacology. 45: 111-9. PMID 10663625 DOI: 10.1007/s002800050018  0.02
2014 Kiguli S, Akech SO, Mtove G, Opoka RO, Engoru C, Olupot-Olupot P, Nyeko R, Evans J, Crawley J, Prevatt N, Reyburn H, Levin M, George EC, South A, Babiker AG, et al. WHO guidelines on fluid resuscitation in children: missing the FEAST data. Bmj (Clinical Research Ed.). 348: f7003. PMID 24423891 DOI: 10.1136/Bmj.F7003  0.02
1998 Crawley JA. Cost effectiveness of treatment for gastro-oesophageal reflux disease. Gut. 43: 729-30. PMID 9917195  0.02
2011 Steinberger J, Belyaeva J, Crawley J, Della-Rocca L, Ebrahim M, Ehrmann M, Kabadjov M, Steinberger R, Van Der Goot E. Highly multilingual coreference resolution exploiting a mature entity repository International Conference Recent Advances in Natural Language Processing, Ranlp. 254-260.  0.02
2011 Nahirya-Ntege P, Musiime V, Naidoo B, Bakeera-Kitaka S, Nathoo K, Munderi P, Mugyenyi P, Kekitiinwa A, Bwakura-Dangarembizi MF, Crawley J. Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy. The Pediatric Infectious Disease Journal. 30: 535-7. PMID 21164384 DOI: 10.1097/INF.0b013e3182076864  0.02
1995 Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PA. Clinical features and outcome of severe malaria in Gambian children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 577-87. PMID 8527547 DOI: 10.1093/CLINIDS/21.3.577  0.019
1997 Khattar RS, Hendel RC, Crawley JC, Wackers FJ, Rigo P, Zaret BL, Sridhara BS, Lahiri A. Improved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 4: 291-7. PMID 9278875  0.019
2016 Paquin K, Crawley J, Harris JE, Horton S. Survivors of chronic stroke - participant evaluations of commercial gaming for rehabilitation. Disability and Rehabilitation. 1-9. PMID 26728133 DOI: 10.3109/09638288.2015.1114155  0.019
2003 Lenderking WR, Hillson E, Crawley JA, Moore D, Berzon R, Pashos CL. The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 6: 560-5. PMID 14627062 DOI: 10.1046/j.1524-4733.2003.65243.x  0.019
2012 Levine OS, Bhat N, Crawley J, Deloria-Knoll M, DeLuca AN, Driscoll AJ, Feikin DR, Karron RA, Murdoch DR, O'Brien KL, Scott JA. Pneumonia etiology research for child health. Introduction. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S87-8. PMID 22403236 DOI: 10.1093/cid/cir1050  0.019
2013 Kekitiinwa A, Cook A, Nathoo K, Mugyenyi P, Nahirya-Ntege P, Bakeera-Kitaka S, Thomason M, Bwakura-Dangarembizi M, Musiime V, Munderi P, Naidoo-James B, Vhembo T, Tumusiime C, Katuramu R, ... Crawley J, et al. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 381: 1391-403. PMID 23473847 DOI: 10.1016/S0140-6736(12)62198-9  0.019
2013 Crawley J, Miller M, Stack MM. An approach to mapping the erosion-corrosion of stainless steel: Applications to tidal energy systems Astm Special Technical Publication. 19-46. DOI: 10.1520/STP156320120118  0.018
2015 Crawley J. Growing connections – the connected professional Research in Post-Compulsory Education. 20: 476-498. DOI: 10.1080/13596748.2015.1081758  0.018
1996 Marsh K, English M, Crawley J, Peshu N. The pathogenesis of severe malaria in African children. Annals of Tropical Medicine and Parasitology. 90: 395-402. PMID 8944083 DOI: 10.1080/00034983.1996.11813068  0.018
2008 Allen L, Black RE, Brandes N, Brittenham G, Chazot G, Chunming C, Crawley J, de Benoist B, Dalmiya N, Darnton-Hill I, Dewey K, El-Arifeen S, Fontaine O, Geissler C, Haberle H, et al. [Conclusions and recommendations of a WHO expert consultation meeting on iron supplementation for infants and young children in malaria endemic areas]. Mã©Decine Tropicale : Revue Du Corps De Santã© Colonial. 68: 182-8. PMID 18630054  0.018
1998 Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 7: 75-83. PMID 9481153  0.018
1997 Murphy SA, Mberu E, Muhia D, English M, Crawley J, Waruiru C, Lowe B, Newton CR, Winstanley P, Marsh K, Watkins WM. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91: 331-4. PMID 9231211 DOI: 10.1016/S0035-9203(97)90097-3  0.018
2000 Crawley J, Kokwaro G, Ouma D, Watkins W, Marsh K. Chloroquine is not a risk factor for seizures in childhood cerebral malaria. Tropical Medicine & International Health : Tm & Ih. 5: 860-4. PMID 11169275 DOI: 10.1046/j.1365-3156.2000.00658.x  0.018
1996 Crawley JI. Rampant absurdities. What's wrong with this picture? Revolution (Staten Island, N.Y.). 6: 48-50. PMID 9043403  0.017
2005 Johnson DA, Orr WC, Crawley JA, Traxler B, McCullough J, Brown KA, Roth T. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. The American Journal of Gastroenterology. 100: 1914-22. PMID 16128933 DOI: 10.1111/J.1572-0241.2005.00285.X  0.016
2009 Duh MS, Gosselin A, Luo R, Lohoues H, Lewis BE, Crawley JA. Impact of compliance with proton pump inhibitors on NSAID treatment. The American Journal of Managed Care. 15: 681-8. PMID 19845420  0.016
2009 Crawley JT, de Groot R, Luken BM. Circulating ADAMTS-13-von Willebrand factor complexes: an enzyme on demand. Journal of Thrombosis and Haemostasis : Jth. 7: 2085-7. PMID 19765211 DOI: 10.1111/j.1538-7836.2009.03621.x  0.016
1995 English M, Murphy S, Mwangi I, Crawley J, Peshu N, Marsh K. Interobserver variation in respiratory signs of severe malaria. Archives of Disease in Childhood. 72: 334-6. PMID 7763067 DOI: 10.1136/adc.72.4.334  0.015
1980 Schleidt WM, Crawley JN. Patterns in the behaviour of organisms Journal of Social and Biological Systems. 3: 1-15. DOI: 10.1016/0140-1750(80)90016-0  0.014
2007 Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, Roman E, Palmer A, Asamoa K, Steketee R. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. The Lancet. Infectious Diseases. 7: 145-55. PMID 17251085 DOI: 10.1016/S1473-3099(07)70026-9  0.014
2009 Crawley JM. "Once upon a time": a discussion of children's picture books as a narrative educational tool for nursing students. The Journal of Nursing Education. 48: 36-9. PMID 19227754 DOI: 10.3928/01484834-20090101-02  0.013
1996 Thorniley MS, Lahiri A, Glenville B, Shurey C, Baker G, Ravel U, Crawley J, Green CJ. Non-invasive measurement of cardiac oxygenation and haemodynamics during transient episodes of coronary artery occlusion and reperfusion in the pig. Clinical Science (London, England : 1979). 91: 51-8. PMID 8774260  0.013
1995 Murphy S, English M, Omar A, Crawley J, Waruiru C, Mwangi I, Amukoye E, Peshu N, Newton CR, Winstanley PA. The management of severe malaria in children: a review. East African Medical Journal. 72: 536-9. PMID 7588152  0.013
2016 Ling TC, Clayton TH, Crawley J, Exton LS, Goulden V, Ibbotson S, McKenna K, Mohd Mustapa MF, Rhodes LE, Sarkany R, Dawe RS. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015 British Journal of Dermatology. 174: 24-55. DOI: 10.1111/bjd.14317  0.011
1998 Holzer SS, Juday TR, Joelsson B, Crawley JA. Determining the cost of gastroesophageal reflux disease: a decision analytic model. The American Journal of Managed Care. 4: 1450-60. PMID 10338737  0.011
2003 Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Alimentary Pharmacology & Therapeutics. 17: 1309-17. PMID 12755844  0.01
2019 Buxbaum JD, Baron-Cohen S, Anagnostou E, Ashwin C, Betancur C, Chakrabarti B, Crawley JN, Hoekstra RA, Hof PR, Lai MC, Lombardo MV, Schumann CM. Rigor in science and science reporting: updated guidelines for submissions to . Molecular Autism. 10: 6. PMID 30828415 DOI: 10.1186/S13229-018-0249-X  0.01
2015 Mehrtens SH, Crawley JM. Pyoderma gangrenosum. British Journal of Hospital Medicine (London, England : 2005). 76: C173-6. PMID 26551510 DOI: 10.12968/hmed.2015.76.11.C173  0.01
2015 Thomas MR, de Groot R, Scully MA, Crawley JT. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. Ebiomedicine. 2: 940-50. PMID 26425702 DOI: 10.1016/j.ebiom.2015.06.007  0.01
2015 Thomas MR, de Groot R, Scully MA, Crawley JTB. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura Ebiomedicine. DOI: 10.1016/j.ebiom.2015.06.007  0.01
2013 Crawley J. 'Endless patience and a strong belief in what makes a good teacher': Teacher educators in post-compulsory education in England and their professional situation Research in Post-Compulsory Education. 18: 336-347. DOI: 10.1080/13596748.2013.847153  0.01
2013 Alemayehu B, Crawley JA, Ke X, Illueca M. Formulary exclusion of esomeprazole: Impact on healthcare costs and utilization American Journal of Pharmacy Benefits. 5: e95-e102.  0.01
2012 Crawley JT, de Groot R. Cardiovascular string theory. Blood. 119: 2181-2. PMID 22403212 DOI: 10.1182/blood-2011-12-397810  0.01
2011 Andreou AP, Crawley JT. Thrombomodulin analogues for the treatment of ischemic stroke. Journal of Thrombosis and Haemostasis : Jth. 9: 1171-3. PMID 21486426 DOI: 10.1111/j.1538-7836.2011.04292.x  0.01
2010 Crawley JB, Wagner G. Desktop text mining for law enforcement Isi 2010 - 2010 Ieee International Conference On Intelligence and Security Informatics: Public Safety and Security. 138-140. DOI: 10.1109/ISI.2010.5484761  0.01
2007 Jimenez CC, Corcoran MH, Crawley JT, Guyton Hornsby W, Peer KS, Philbin RD, Riddell MC. National athletic trainers' association position statement: management of the athlete with type 1 diabetes mellitus. Journal of Athletic Training. 42: 536-45. PMID 18176622  0.01
2007 Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR. ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood. 109: 1998-2000. PMID 17053057 DOI: 10.1182/blood-2006-07-038166  0.01
2005 Carrau RL, Khidr A, Gold KF, Crawley JA, Hillson EM, Koufman JA, Pashos CL. Validation of a quality-of-life instrument for laryngopharyngeal reflux. Archives of Otolaryngology--Head & Neck Surgery. 131: 315-20. PMID 15837899 DOI: 10.1001/archotol.131.4.315  0.01
2004 Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. The Laryngoscope. 114: 670-4. PMID 15064622 DOI: 10.1097/00005537-200404000-00014  0.01
1998 Hokfelt T, Bartfai T, Crawley J. Preface Annals of the New York Academy of Sciences. 863. DOI: 10.1111/j.1749-6632.1998.tb10678.x  0.01
Hide low-probability matches.